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ABSTRACT 
 
Ribosome inactivating proteins (RIPs) are a family of plant proteins that irreversibly arrest 
protein synthesis through depurination of rRNA. The anticancer, antiviral and neurotoxic 
properties allow RIPs to have useful applications in agriculture and in many biomedical 
fields, including clinical drug development. 
Galactose–binding lectins contained in caudices of four Adenia species were purified by 
affinity chromatography on CL Sepharose 6B. All lectins agglutinate human erythrocytes. 
The lectin from A. kirkii, called kirkiin, had the highest toxicity, inhibiting protein 
synthesis both by cell-free system and by whole cells, and deadenylates mammalian and 
yeast ribosomes. Kirkiin is highly toxic to cells, in which it induces apoptosis with EC50 
(concentration reducing viability by 50%) of 10-14M after 72h. Analysis of the genomic 
clones encoding kirkiin reveals a high degree of sequence similarity to other type 2 RIPs. 
Molecular modeling confirmed that kirkiin have a similar structure to ricin. Thus, kirkiin 
shows all the properties of a toxic type 2 RIP and is amongst the most potent plant toxins.  
The pathogenesis of cell intoxication induced by the non-toxic type 2 RIPs from 
Sambucus, ebulin l and nigrin b, was investigated in a neuroblastoma-derived cell line 
(NB100), which showed to be very sensitive to RIPs. Despite the high translational 
inhibition activity in cell-free systems, both RIPs showed a low cytotoxicity in NB100 
cells with respect to both type 1 and type 2 RIPs. The results revealed that the mechanism 
of cell death induced by Sambucus RIPs (10-8M) is partly due to caspase-dependent 
apoptosis and suggest the existence of a further cell death pathway that would be prevalent 
at the early 24h of intoxication and that is different from necrosis, necroptosis and 
autophagy. A block of cell cycle can be excluded. After 24h, the apoptotic pathway 
becomes the main route of cell death. 
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1.1 General properties 
1.1.1 Ribosome-inactivating proteins (RIPs) 
Ribosome-inactivating proteins (RIPs) are a family of proteins widely spread in the 
plant kingdom, purified from different angiosperms, monocots and dicots, but also 
present in some fungal and bacterial species (Stirpe, 2013). More than 50 species of 
plants belonging to 17 families have been reported to contain RIPs. The designation 
RIPs is related to their rRNA N-glycosidase activity, which makes them able to 
inactivate eukaryotic ribosomes through the removal of one or more adenines from 
rRNA and other nucleotide substrates, irreversibly blocking the cell protein synthesis 
and causing death (Barbieri et al., 2003; Walsh et al., 2013). 
The biological effects of RIPs have been known since ancient times, such as the 
abortifacient activity of Trichosanthes kirillowii and Mormordica charantia. Ricin, 
extracted from the seeds of Ricinus communis, was one of the first RIPs to be 
discovered in 1888 by Stillmark, who found that the toxin caused erythrocyte 
agglutination and precipitation of serum proteins (Stillmark, 1888). Subsequently, other 
plant toxins with similar properties have been identified, such as abrin from Abrus 
precatorius seeds (Martin, 1887). In 1970, Lin and co-workers discovered that these 
toxins showed a higher toxicity against tumor cells compared to normal cells (Lin et al., 
1970). Years later, Stirpe introduced the term RIP for plant proteins able to inactivate 
animal ribosomes, when enzymatic activity and structure were still unknown (Stirpe, 
1982). When their enzymatic activity was clarified, the term RIP was attributed only to 
proteins capable of catalyzing the endohydrolysis of the N-glycosidic bond at a specific 
adenine of the 28S rRNA of the large 60S ribosomal subunit (Endo et al., 1987). Other 
proteins can inactivate or damage ribosomes with different mechanisms, but they are 
not called RIPs. Later, it has been found that some RIPs can remove more than one 
adenine residue per ribosome (Barbieri et al., 1994) and even from DNA and other 
polynucleotides. As a consequence, the name adenine: polynucleotide glycosylase was 
proposed for these proteins (Barbieri et al., 2001). 
The expression level of RIPs in plant tissues is highly variable, ranging from traces to 
hundreds of milligrams per 100 grams of tissue. In some plants these proteins are 
expressed in many of examined tissues (roots, leaves, buds, flowers, fruits, seeds, bark, 
latex, plant cells in culture), while in other plants they are present in a single tissue 
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(Ferreras et al.,1993; Girbes et al., 2003). In other cases, RIPs may have a specific 
localization. Moreover, the expression seems to increase during senescence, in 
unfavorable conditions (Stirpe et al., 1996) and in virally infected cells (Barbieri et al., 
2001). 
Despite their wide distribution among plants, the physiological role of RIPs is still 
unclear. It has been hypothesized a possible defensive mechanism of plants against 
biotic and abiotic stresses (Nielsen et al., 2001; Polito et al., 2013). 
RIPs are not limited to the plant kingdom. Bacterial RIPs include Shiga and Shiga-like 
toxins are produced by gram-negative pathogenic bacteria as virulence factors (Walsh et 
al., 2013). RIPs have been also identified in mushrooms, such as α-sarcin, purified from 
Aspergillus giganteus (Xu et al., 2011). 
1.1.2 Classification of RIPs 
Studies on the structure and genetics of RIPs allowed identifying their primary 
structure, as well as information on the mechanism of action. According to their 
physical characteristics and the presence or absence of a lectin-like chain, RIPs are 
divided into two groups: type 1 and type 2. 
The first group consists of proteins characterized by a single polypeptide chain of about 
30 kDa with enzymatic activity. Instead, the second group includes toxins with 
molecular weight of 60-65 kDa, consisting of two polypeptide chains: an enzymatically 
active A-chain, with properties similar to type 1 RIPs, linked to a B-chain with lectin 
properties. The B-chain has strong affinity for sugar moieties of cell surface and can 
facilitate the entry of the toxin into the cell (Walsh et al., 2013). The two chains are 
linked by hydrophobic interactions and by at least one disulfide bridge (Girbes et al., 
2003). 
A third group of RIPs has been identified, which consist of an active chain linked by 
peptide bond to a second chain whose function is not yet known (Peumans et al., 2001). 
This group includes only two proteins, b-32 from Zea mays (corn) (Walsh et al., 1991) 
and JIP60 from Hordeum vulgare (barley) (Reinbothe et al., 1994) (figure 1.1). 
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Fig. 1.1. RIPs structural classification. 
Type 1 RIPs 
These enzymes are widely distributed in nature and have been extracted from plants 
belonging to families even phylogenetically distant from each other (table 1.1). Notably 
examples are pokeweed antiviral protein (PAP), saporin (Saponaria officinalis), 
dianthin (Dianthus caryophyllus) and momordin (Momordica charantia). Type 1 RIPs 
are basic proteins (usually with a pI ≥ 9.5). Most of them, with the exception of those 
from Poaceae, are synthesized from intron-less genes as pre-proteins with a signal 
peptide, the mature protein and a C-terminal extension (Nielsen et al., 2001). They are 
synthesized on ER and then follow the secretory pathway to be finally secreted from the 
cell or targeted to the vacuoles (Hartley and Lord, 2004). For example, PAP is located 
in the cell wall matrix and in some vacuoles (Ready et al., 1986), while saporin is 
present in the intercellular spaces, in the paramural region between the primary wall and 
plasmalemma and within the vacuole of the periplasmic cells (Carzaniga et al., 1994). 
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Table 1.1. Some type 1 RIPs. Data from Schrot et al., 2015. 
Caryophyllaceae 
Agrostemma githago  Agrostin 2,5 e 6 seeds 
Dianthus barbathus  Dianthin 29 leaves 
Dianthus caryophyllus  Dianthin 30 e 32 leaves 
Dianthus sinensis  RIP 1,2,3 leaves  
Lychnis chalcedonica  Lychnin seeds 
Saponaria ocymoides  Ocymoidine seeds 
Saponaria officinalis Saporin S5, S6, S8, S9 seeds 
 Saporin L1, L2 leaves 
 Saporin R1, R2, R3 roots 
Vaccaria pyramidata  Pyramidatine seeds 
Cucurbitaceae 
Benincasa hispida var. 
chieh-qua 
Hyspidin seeds 
Bryonia dioica Bryodin-L leaves 
 Bryodin 1 e 2 roots 
Luffa acutangula  Luffaculin seeds 
Luffa aegyptiaca  LRIP (Luffin c) seeds 
Luffa cykubdruca  Luffin a e b seeds 
Luffa cylindrica  Luffin S seeds 
 Luffacilina seeds 
Momordica balsamina Momordin II  
Momordica charantia Momordin I seeds 
 α, β MMC seeds 
 Charantin seeds 
Momordica cochinchinensis Momorcochin S seeds 
 Momorcochin R roots 
Trichosanthes cucumerina Trichoanguin seeds 
Trichosanthes cucumeroides B trichosanthin roots  
Trichosanthes kirilowii S-Trichokirin seeds 
 
Trichosanthin TAP29 
TCS α, β, γ roots 
Euphorbiaceae 
Croton tiglium  Crotin I e II (2, 3) seeds 
Gelonium multiflorum  Gelonin (GAP)  
Jatropha curcas  Curcin 2 seeds 
Manihot palmat  Mapalmin seeds 
Manihot utulissima  Manutin 1 e 2 seeds 
Phytolaccaceae 
Phytolacca americana PAP I, PAP II leaves 
 PAP-S1 e S2 seeds 
 PAP-R roots 
Phytolacca dioica  PD-S1, S2, S3 seeds 
 PD-L1, L2, L3, L4 leaves 
Phytolacca dodecera  Dodecandrin leaves  
Phytolacca acinosa PAP  
Phytolacca insularis PIP leaves 
 PIP 2 cdna 
Lauraceae 
Cinnamomun camphora  Camphorin seeds 
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Type 2 RIPs 
These enzymes can be heterodimeric or tetrameric, with a molecular mass of 60 kDa or 
120 kDa, respectively. The majority of type 2 RIPs known are heterodimers composed 
of an A-chain linked to a B-chain, like abrin, modeccin, ricin, volkensin and 
stenodactylin. The tretameric protein is the result of the union of two heterodimers by 
another disulfide bond between the two B-chains, such as Ricinus agglutinin (RCA) 
(Van Damme et al., 2001). 
Ricin is the best-characterized RIP in terms of gene structure. Genomic and 
transcriptomic analyses show that ricin is synthesized in the developing endosperm of 
R. communis seeds from a single mRNA that encodes a preprotein known as 
preproricin, which contains the A- and B-chains. The first 35 amino acids of preproricin 
correspond to the signal peptide important for translocation of the protein to the 
endoplasmic reticulum (ER) lumen. (Lamb et al., 1985). Here the signal peptide is 
cleaved and four exposed asparagine residues are N-glycosylated, and five disulfide 
bridges are formed to obtain the proricin. The linker peptide between the two chain 
sequences is a signal for vacuolar sorting (Frigerio et al., 2001). Therefore, the proricin 
is transported via the ER and the Golgi complex into protein storage vacuoles, where 
the proteolytical removal of the linker peptide occur to form the mature ricin (Lord et 
al., 1994). It seems that all type 2 RIPs are synthesized in a similar way. 
The presence of a lectin B-chain, which facilitates the translocation of the A-chain into 
the cytosol by interaction with galactosyl residues of membrane glycoproteins and/or 
glycolipids, makes type 2 RIPs highly toxic. In fact, these RIPs are 104 -105 times more 
toxic than their type 1 counterparts in cultured cells and 103 times more toxic in animals 
(Ready et al., 1984; Battelli, 2004). However, a number of type 2 RIPs display low or 
no cytotoxicity despite possessing the lectin B-chain and strongly inhibiting protein 
synthesis in free-cell systems. Their low toxicity may be due to low affinity for 
membrane galactosyl residues which alter their intracellular routing (Girbes et al., 2003; 
Ferreras et al., 2011). 
Toxic type 2 RIPs have only been identified in six plants, which are members of 
Euphorbiaceae, Fabaceae, Passifloraceae, and Viscaceae, while non-toxic type 2 RIPs 
have been identified in Euphorbiaceae, Sambucaceae, Lauraceae, Ranunculaceae, 
Liliaceae and Iridaceae (table 1.2). 
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Table 1.2. Type 2 RIPs. Data from Schrot et al., 2015. 
Euphorbiaceae 
Ricinus communis Ricin (D, E) Seeds 
 
RCA (Ricinus 
communis agglutinin) 
Fabaceae 
Abrus precatorius Abrin a, b, c, d Seeds 
Abrus pulchellus  Pulchellins Seeds 
Iridaceae 
Iris holleica  IRA-b e IRA-r bulbs 
Lauraceae 
Cinnamomum, camphora  cinnamomin seeds 
Cinnamomum porrectum  porrectin seeds 
Liliaceae 
Poligonatum multiflorum  PMRIPm e PMRIPt leaves 
Passifloraceae 
Adenia volkensii  Volkensin roots 
Adenia stenodactyla  Stenodactylin caudex 
Adenia digitata  Modeccin 4B and 6B roots 
Ranunculaceae 
Eranthis hyemalis  
 
EHL, Eranthis 
hyemalis lectin 
bulbs 
Sambucaceae 
Sambucus ebulus Ebulin l leaves 
 
Ebulin r1 e r2 rizhome 
Ebulin f fruits 
Sambucus nigra Nigrin f, SNA-If fruits 
 
Nigrin b, SNAI, SNAI’, 
Basic Nigrin b, SNLRP1 2 
barks 
Nigrin l1 e l2, SNAld leaves 
Nigrin s, SNAIII seeds 
Sambucus racemosa  Basic racemosin barks 
Sambucus sieboldiana Sieboldin b and SSA barks 
Viscaceae 
Phoradendron californicum 
 
PCL, Phoradendron 
californicum lectin 
leaves 
 
Viscum album  MLI (viscumin), II, III leaves 
1.1.3 RIP tridimensional structure 
Despite RIPs have been object of a large number of studies, their biological role has 
never been ascertained. Structure and sequence analyses of RIPs have been performed 
to better understand the protein function and the relationship between structure and 
cytotoxicity. 
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N-terminal sequence of many RIPs are known and the complete sequence and the three-
dimensional structure of several RIPs are available. A comparison of amino acid 
sequences shows similarity between the type 1 and the A-chains of type 2 RIPs and 
among the B-chains of type 2 RIPs. However, the homology among N-terminal amino 
acid sequences is higher than C-terminal sequences (Hartley et al., 1996). Ricin was the 
first RIP analyzed by X-ray diffraction and its structure was published in 1987 
(Montfort et al., 1987; Rutenber et al., 1991). The X-ray diffraction data revealed it is 
composed of two polypeptide chains, an A-chain (RTA) with the enzymatic activity of 
inactivating ribosomes, linked by a disulphide bond to a lectinic B-chain (RTB) with a 
galactose-specificity, which allows it to bind to cells (Olsnes and Pihl, 1973). RTA was 
found to be a globular protein of 267 amino acids folded into three domains with eight 
α-helical and six β-strand structures. RTB consists of two homologues globular 
domains, characterized by twelve antiparallel β-strands connected by β-turns and Ω 
loops. Each domain is organized around two disulfide bridges in a trefoil structure with 
three lobes arranged in a symmetrical manner (beta trefoil structure) (Villafranca and 
Robertus, 1981) and is composed of three subdomains (1α, 1β and 1γ for the domain 1 
and 2α, 2β and 2γ for the domain 2). Only 1α and 2γ subdomains show galactoside-
binding activity (Rutember et al., 1987).  
Despite the amino acid sequence may highly vary, the superimposition of the 
crystallized structures of RIPs have been shown to share a common fold and the 
catalytic mechanism of RTA (de Virgilio et al., 2010). To date, the crystal structures 
reported in Protein Data Bank (PDB) are 153, including same RIPs with amino acid 
substitutions or different binding compounds (i.e. active site substrates and sugar 
binding molecules). The structure of type 1 and the A-chains of type 2 RIPs is very 
similar with the exception of N- and C-terminal, which can vary in length and therefore, 
assume different conformations (Robertus and Monzingo, 2004). Although the high 
variability, several amino acid residues are highly conserved among type 1 and the A-
chains of type 2 RIPs and seem to be important for the catalytic activity. Based on ricin 
A-chain sequence, Tyr80, Tyr123 and Trp211 are the most conserved residues directly 
involved in the binding to the substrate, while Glu177 and Arg180 are involved in the 
catalytic mechanism responsible of the N-glycosidase activity of the protein. Site-direct 
mutagenesis studies showed that the mutation of amino acids important for the catalytic 
activity causes a substantial reduction in activity. Frankel and co-workers found that a 
positive charge at position Arg180 in RTA is essential for the solubility and the 
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enzymatic activity (Frankel et al., 1990); the conversion of Glu177 to Gln reduces 
enzyme activity of about 200-fold (Ready et al., 1991). In the case of saporin-6, Tyr72 
(Tyr80 in ricin) mutation is crucial for the catalytic activity of the protein with respect 
to Tyr120 (Tyr123 in ricin) mutation; the mutants of Glu176 (Glu177 in ricin) and 
Arg179 (Arg180 in ricin) are 20-fold and 200-fold less active than the wild-type, 
respectively (Bagga et.al., 2003). Interestingly, mutation of Trp208 in saporin (Trp211 
in ricin) do not affect its in vitro enzymatic activity and cytotoxicity (Bagga et al., 
2003), but the same amino acid is important for the structural integrity of PAP 
(Rajamohan et al., 2000). The target adenine is inserted inside the catalytic cleft, where 
the architecture of both invariant tyrosine rings is appropriate for sandwiching the 
aromatic ring of the adenine (Mozingo and Robertus, 1992). The structure of the 
catalytic site cleft remains constant among RIPs, with the exception of the orientation of 
some side-chains and the number of hydrogen bonds and water molecules that can be 
vary. Tyr80 is the most variable residue in the active site, whose side-chain can assume 
a range of positions (Husain et al., 1994). Thanks to its flexibility, Tyr80 seems to work 
as a moving door allowing the substrate to enter and assume the best favorable 
orientation in the active site (Vater et al., 1995; de Virgilio et al., 2010). The adenine-
binding site can also hold guanine (in PAP and trichosanthin) or pteroic acid (in ricin 
and PAP) (Yan et al., 1997; Kurinov et al., 1999; Gu and Xia, 2000). This suggests that 
the enzymatic activity is not directed only toward adenine, but also toward other purine 
derivatives. Other residues are highly conserved in the type 1 and the A-chains of type 2 
RIPs and are mainly involved in the stabilization of the catalytic conformation (Katzin 
et al., 1991; Hao et al., 2001). Not conserved amino acids in the active site can 
participate in the binding to the substrate, indicating that different RIPs can bind the 
adenine target in different ways. A group of highly conserved amino acids has been 
identified outside of the active site, creating a sort of internal structure that probably 
gives a support to the RIP catalysis. (Di Maro et al., 2014). 
As for the A-chains, the three-dimensional structure of the B-chains of type 2 RIPs is 
very similar. Nevertheless, there are remarkable differences in amino acids residues of 
galactose binding sites. This explains the different binding specificity. The 1α 
subdomain presents a lower affinity for lactose than 2γ subdomain (Hatakeyama et al., 
1986). Moreover, 2γ subdomain can bind the N-acetylgalactosamine (GalNAc), while 
this binding cannot occur in 1α subdomain, due to steric hindrance (Rutenber and 
Robertus, 1991). The main differences in the primary sequence are observed in the 
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galactose binding residues, especially in Tyr248 in 2γ subdomain. The presence of a 
positive charge in this domain causes a loss of functionality because the hydrophobic 
interaction between the pyranose ring of galactose and the aromatic ring of Tyr is lost 
(Van Damme et al., 2000). X-ray crystallography of ebulin l (a non-toxic type 2 RIP) 
revealed changes in crucial amino acids within the 2γ sugar binding site, which cause a 
reduction of the affinity for the galactoside residues of cell membrane surface, thus 
reducing the cytotoxicity of the protein (Ferreras et al., 2010). This suggests that the 
carbohydrate-binding properties play an important role in the cytotoxicity of type 2 
RIPs. Other highly conserved residues located in the core of the two domains are not 
involved in the sugar-binding, but they have an important structural function in 
preserving the symmetry of the domains (Feng et al., 2010). 
1.1.4 Interaction of RIPs with cells: mechanism of entry 
Differences in cytotoxicity between type 1 and type 2 RIPs are related to the different 
interactions of these proteins with cells, which appear to depend on the protein 
structure. The presence of a lectin B-chain allows type 2 RIPs to interact with galactose-
containing glycoproteins and glycolipids on the cell surface, promoting their cell entry 
(Stirpe, 2004). An alternative mechanism involves the interaction between mannose cell 
receptors and carbohydrate side chains that are present in the toxin. 
Most of the knowledge on cell entry mechanism of type 2 RIPs comes from studies on 
ricin. Ricin and possibly other type 2 RIPs can reach the endosomal compartment 
through clathrin-dependent or clathrin-independent mechanisms (Sandvig and van 
Deurs, 1996). The RIP can bind to receptors located in specialized depressions of cell 
membrane, giving rise to clathrin-coated vesicles (Giansanti et al., 2010). However, 
experimental evidence showed that clathrin-dependent endocytosis mechanism is not 
crucial f or toxin cell entry and that ricin mostly acts by RIP-receptor recognition (Puri 
et al., 2012). Once inside the cell, the RIP could be recycled to cell surface or 
transported to lysosomes for degradation or translocate to the Golgi apparatus. The 
different destination might cause different cytotoxicity. The majority of RIPs translocate 
to the Golgi apparatus and follow retrograde transport to the endoplasmic-reticulum 
(ER), then enter the cytosol interacting with the ER-associated degradation pathway 
(ERAD) machinery (Sandvig et al., 2005). Since translocation through the ER 
membranes causes the unfolding of the protein with loss of activity, it seems that RIPs 
are able to escape degradation, because they contain a low number of lysines, which 
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make them resistant to proteolysis (Johannes et al., 2008). In ER lumen the disulfide 
bond that links the two chains of the RIP is reduced (Mayerhofer et al., 2009). In the 
case of ricin, only the 5% translocate to the Golgi apparatus (van Deurs et al., 1988) and 
this represents the portion of toxin responsible of cell intoxication. The non-degraded 
form of the toxin is excreted by cells and is available for further entry into other cells 
(Battelli et al., 2004; Hartley and Lord, 2004). 
The reduced toxicity of non-toxic type 2 RIPs depends in part on their inefficient ability 
to translocate within cells. For example, ebulin l showed low affinity to membrane 
galactosyl residues (Pascal et al., 2001; Ferreras et al., 2011). However, the low 
cytotoxicity of this type of RIPs is also linked to their intracellular destination. As ricin, 
nigrin b can enter the cell, but it is more rapidly and extensively degraded and excreted 
from the cell (Battelli et al., 1997). Although volkensin is excreted by cells faster than 
ricin, it shows higher toxicity. This could be due to the low content of lysines which 
make it resistant to proteolysis. The most toxic type 2 RIPs stenodactylin and lanceolin 
have the same intracellular routing of ricin, but their high cytotoxicity seems to be 
related to their high affinity to receptors, greater uptake and lower proteolysis, which 
allows the re-uptake of non-degraded RIPs (Battelli et al., 2010). The low cytoxicity of 
type 1 RIPs is explained by the absence of the lectin chain, which reduces entry to the 
cells (Barbieri et al., 1993). The endocytic mechanism of type 1 RIPs is still unclear and 
different hypotheses have been proposed. They can be internalized similarly to type 2 
RIPs, after binding to either the galactosyl residues or the mannose receptor on the cell 
membrane (Cavallaro et al., 1995). A further hypothesis suggests the cell entry by 
passive “fluid phase” endocytosis (pinocytosis), which allows the internalization of the 
toxin without receptor binding (Madan and Ghosh, 1992). This means that the toxicity 
is lower than type 2 RIPs, but high in cells in which the pinocytosis is a common 
process, such as macrophages and trophoblast. Saporin follows a Golgi-independent 
pathway to the cytosol (Vago et al., 2005) and recently, it has been observed its nuclear 
localization (Bolognesi et al., 2012). Instead, PAP presents retro-translocation 
mechanism from the ER to the cytosol, similar to type 2 RIPs (Parikh et al., 2005). This 
observation suggests that type 1 RIPs may also be able to follow the cellular route for 
misfolded proteins without being degraded by the proteosome. This evidence indicate 
that the intracellular routing of type 1 RIPs shows diversity within the group or 
depending on the cell type. 
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1.2 Biological activities of RIPs 
1.2.1 RNA N- glycosylase activity 
RIPs have the common ability to induce an irreversible inactivation of ribosomes, 
causing the arrest of protein synthesis. This enzymatic RNA N-glycosidase activity, 
defined ribotoxic activity, is caused by the internalization and activation of the A-chain 
and for a long time it has been considered as the only enzymatic process caused by RIPs 
(Endo et al., 1987). To date, it has been discovered that RIPs have a number of different 
enzymatic activities, most of which can be simply a reflection of their activity on the 
rRNA, whereas other mechanisms are completely new (Girbes et al., 2004). RIPs are 
officially classified as rRNA N-glycosylases (EC 3.2.2.22). They recognize a specific 
and universally conserved region of 14 nucleotides on 28S rRNA, splitting the N-C 
glycosidic bond between a specific adenine and its ribose in the sequence GAGA on the 
rRNA. In the case of rat liver ribosomes, this site is A4324 and is positioned within a 
single-stranded loop called sarcin/ricin, located in the VII domain of the ribosome 
(Endo et al., 1987) (figure 1.2). This region is the site of interaction of the ribosome 
with elongation factors. After adenine removal, the apurinic site does not allow the 
GTPase-dependent binding of elongation factor-1 (EF-1) and elongation factor-2 (EF-2) 
to the 60S subunit of the ribosome, thus blocking the translation (Stirpe et al., 2006). 
Sarcin/ricin loop is highly conserved across species, being found in 28S rRNA of rat 
and Xenopus, in 26S rRNA of yeast and in 23S rRNA of E. coli. All RIPs exhibit RNA 
N-glycosylase activity on ribosomes with differences in the specificity for the substrate. 
N-terminal end of these toxins seems to determine the substrate specificity. In general, 
type 2 RIPs seem to be more active on animal ribosomes, whereas type 1 RIPs have a 
wider specificity. For example, the type 1 RIP PAP can remove adenine on ribosomes 
of plants, yeasts, bacteria and animals. Instead, other RIPs, such as ricin, are very active 
on ribosomes of animals and yeasts, but their activity is very low or absent on plants 
and E. coli ribosomes (Barbieri et al., 1993). 
The activity on and the specificity for the substrate is not only determined by the 
structural diversity of RIPs, both by the ribosomal proteins, that can facilitate or not the 
RIP access to the GAGA loop. Several experimental evidence show that ribosomes have 
different sensitivity to the toxins, such as L9 and L10 ribosomal proteins of rat liver, 
that are the main binding target of ricin (Vater et al., 1995), while L3 ribosomal protein 
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of yeast is the binding target of PAP (Hudak et al., 1999). L3 ribosomal protein is 
highly conserved and this would explain the wide spectrum of specificity of PAP to 
ribosomes of different organisms. 
Although native ribosomes are the favorite substrate, RIPs can also act on naked rRNA 
(deproteinized) at higher concentrations than those needed toact on intact ribosomes 
(Endo et al., 1991). It is interesting to note that some RIPs can deadenilate naked rRNA 
derived from ribosomes on which they normally do not show specificity. For example, 
ricin A-chain does not act on intact E. coli ribosomes, but it is able to deadenilate its 
naked 23S RNA. 
Usually a single adenine is removed from ribosomes, but some RIPs, such as saporin, 
PAP and trichosanthin, are capable of mediating multiple depurination (Barbieri et al., 
1994).  
 
 
 
Fig. 1.2. Enzymatic mechanism of RIPs. 
1.2.2 Polynucleotide:adenosine glycosylase activity (PNAG) 
Through the development of fluorescence-based HPLC-methods (Zamboni et al., 1989), 
RIPs were shown to act on other nucleotide substrates, such as herring sperm DNA, 
tRNA, mRNA and viral RNA (Girbés et al., 2004). Based on the observation that RIPs 
can deadenylate a range of polynucleotides, the term polynucleotide:adenosine 
glycosidases (PNAG) was proposed (Barbieri et al., 2001). RIPs show significant 
differences in PNAG activity, probably due to structural changes and to the type of 
substrate, as well as to experimental conditions. PNAG activity of all toxic type 2 RIPs 
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is significantly lower than type 1 RIPs; the reduction of the interchain disulfide bridge 
does not improve PNAG activity (Barbieri et al., 1997). 
Recently, it has been observed that RIPs are able to remove adenine from ADP-ribose 
chain of the activatedpoly (ADP-ribose) polymerase, which is involved in the DNA 
repair mechanism (Barbieri et al., 2003). The damage of the polymerase can have a role 
in the inhibition of DNA repair, which seems to be independent from inhibition of 
protein synthesis (Sestili et al., 2005). Ricin and PAP also exhibit a guanosine 
glycosidase activity and can remove guanine residues from both prokaryotic and 
eukaryotic rRNA (Endo et al., 1987; Rajamohan et al., 1999).  
1.2.3 Effects on laboratory animals and humans 
The toxicity of RIPs have been investigated in numerous studies both in vitro and in 
vivo. Type 2 RIPs are more toxic than type 1 RIPs, thanks to the presence of the B-
chain, which promotes the binding to cells and the subsequent internalization. 
There is no evidence about the effect of type 1 RIPs in humans. However, trichosanthin 
showed to induce abortion (Lu and Jin, 1989) with fever, headache and joint pain, that 
disappear after 48 hours; it also causes skin rashes, muscle pain and neurological 
problems in HIV-infected patients (Byers et al., 1994; Kahn et al., 1990). 
The toxicity of toxic type 2 RIPs and the symptoms produced after ricin poisoning have 
been known for a long time (Balint, 1974). Low doses of ricin produce digestive tract 
convulsions, whereas higher doses cause gastrointestinal symptoms, with subsequent 
hemorrhaging in the stomach and intestine, and degenerative diseases of the heart, liver 
and kidney, with consequent death. The inhalation of small particles induce severe 
respiratory symptoms (Balint, 1974). 
The effects of RIPs have been mainly studied in rats, in which the onset of severe 
damages to the liver, kidney and spleen were observed. The precocity and severity of 
lesions induced by toxic type 2 RIPs is dose-dependent: high doses kill rats in a very 
short time, even when parenchymal organs have not yet fatal injuries. Ricin, modeccin 
and volkensin cause severe injuries in liver with consequent necrosis; ricin is the first to 
damn non-parenchymal cells (Stirpe, 2004), probably because of the cell macrophage 
activity, which allows to easily identify the toxin. These toxins were found to induce the 
production of tumor necrosis factor (TNF) and interleukins by human mononuclear cells 
(Licastro et al., 1993; Hajto et al., 1990; Yamasaki et al., 2004). This could explain the 
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toxicity observed in animals poisoned with these toxins. Abrin causes necrosis of acinar 
pancreatic cells (Barbieri et al., 1979). Apoptotic changes were observed in the intestine 
and lymphoid tissues of the rat poisoned with abrin and ricin (Griffiths et al., 1987). No 
severe lesions were observed in rats poisoned with viscumin or volkensin (Stirpe, 
2004). Always in mice, high doses of nigrin b cause intestinal problems (Girbes et al., 
2003). Type 1 RIPs administered to mice at high doses were shown to induce damages 
in the liver, kidney and spleen, and also necrosis (Battelli et al., 1990). 
RIPs are strongly immunogenic. In particular, they show high cross reactivity with RIPs 
belonging to the same family (Strocchi et al., 1992), but they can cross react also with 
sera against RIPs of different families, as shown by lanceonin with the anti- PAP R and 
anti-momordin I sera (Stirpe et al., 2007). The onset of an immune reaction against 
RIPs was also observed in laboratory personnel working with them (Szalai et al., 2005). 
These toxins are also present in edible plants, including species that are eaten raw, and 
their allergenic properties might be the cause of allergies induced by some vegetables 
(Barbieri et al., 2006; Stirpe et al., 2006). 
1.2.4 Retrograde axonal transport 
Some toxic RIPs, including ricin, abrin and viscumin can be retrogradely transported 
along axons of the peripheral nerves to the cell body, where they inactivate ribosomes, 
resulting in neuronal death (Wiley and Kline, 2000). This process is called "suicide 
transport" and several studies have been done for the use of these toxins in the 
functional anatomy of neurons and to prospect a powerful new experimental strategy for 
the treatment of neurobiological problems (Harper et al., 1980; Yamamoto et al., 1985; 
Wiley and Oeltman, 1986; Paul and Devor, 1987). Adenia RIPs, including modeccin, 
volkensin (Harrison et al., 1990), stenodactylin and lanceolin (Monti et al., 2007) can 
be retrogradely transported not only along the peripheral nerves, but also along the 
central nervous system. These properties make Adenia RIPs a useful tool for the study 
of the functional anatomy of the central nervous system. In addition, lanceolin and 
stenodactylin displayed neurotoxicity in cells of the cerebellum granules, astrocytes and 
microglia (Monti et al., 2007). The latter appeared to be the most sensitive to the action 
of the two toxins, probably due to their efficient internalization and the damage caused 
by a prolonged inhibition of protein synthesis (Battelli, 2004). The retrograde axonal 
transport can be used both to induce the degeneration or death of specific neurons and in 
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immunolesioning experiments, which consist in the use of immunoconjugates made of 
monoclonal antibodies and RIPs. The most interesting results were obtained with 
saporin-S6 (type 1 RIP) conjugated to the antibody OX7, specific for rat Thy 1, that is 
an antigen expressed on the neurons of the central nervous system (Wiley and Kline, 
2000). This immunotoxin has been used with great success for the study of nerve 
connections.  
The specific localization in the system central nervous of these toxins, both natural and 
inserted into artificial hybrid, depends on the vector, that in the case of natural 
molecules is represented by the B-chain of the RIPs. Therefore, this can prospect a use 
of the B-chain as a carrier for drugs and growth factors at specific sites difficult to 
reach. 
1.2.5 RIPs and cell death mechanisms 
It was initially thought that RIPs cytotoxicity was correlated to protein synthesis 
inhibition resulting from ribosomal damage, thus causing necrosis in the intoxicated 
cells. However, subsequent studies demonstrated that RIPs were able to induce 
apoptosis. In 1987, Griffiths and collaborators were the first to observe the ability of 
ricin and abrin to induce apoptosis after intramuscular injection into rats (Griffiths et al., 
1987) and subsequently, apoptotic events were evidenced in ricin treatment of bovine 
pulmonary endothelial (Hughes et al., 1996) and human macrophage U937 cells (Kochi 
and Collier, 1993). Several other RIPs demonstrated to induce apoptosis, such as 
viscumin (Bussing et al., 1996), saporin (Bergamaschi et al., 1996; Bolognesi et al., 
1996), pokeweed anti-viral protein from seeds (PAP-S), momordin (Bolognesi et al., 
1996) trichosantin (Zhang et al., 2001; Li et al., 2007), volkensin (Bussing et al., 1998). 
The ability of type 1 and type 2 RIPs to induce cell death by apoptosis was extensively 
demonstrated both in vitro and in vivo models (Rao et al., 2005; Zhang et al., 2012; 
Fang et al., 2012). Cells exposed to RIP-intoxication undergo apoptosis via different 
mechanisms, including the loss of mitochondrial transmembrane electrical potential 
gradient (∆ψm), caspase activation and regulation of apoptotic proteins (Kim et al., 
2004; Narayan et al., 2005). However, many questions have remained opened about the 
mechanism of RIP-induced apoptosis and the relationship between RIP N-glycosidase 
activity and the apoptotic events. Some reports indicate that protein synthesis inhibition 
is necessary for triggering apoptosis, but there is evidence that programmed cell death 
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occurred independent of protein synthesis inhibition. As result, three different 
hypotheses have been formulated concerning the rRNA N-glycosidase activity of RIPs: 
(i) indispensable, (ii) necessary but not sufficient or (iii) not relevant for the induction of 
apoptosis (Das et al., 2012). 
Kochi and Collier proposed that apoptotic events became visible only when protein 
synthesis is inhibited by about 90% (Kochi and Collier, 1993). On the contrary, 
rhabdomyosarcoma cells exposed to α-sarcin showed apoptotic characteristics even at 
concentration below its IC50, whereas in the presence of the protein synthesis inhibitor 
cycloheximide any apoptotic events was induced, even at concentrations that abolished 
protein synthesis (Olmo et al., 2001). Moreover, in addition of the pan caspase inhibitor 
Z-VAD-fmk, protein synthesis was not inhibited. 
Many temporal/dose and mutagenesis studies evidenced the independence of the two 
events. For example, in ricin-treated cells morphological changes and the loss of 
mitochondrial membrane potential were observed before translation was completely 
inhibited (Soler-Rodrìguez et al., 1993). Mutant saporin lacking the inhibition activity 
of protein synthesis was reported to induce apoptotic cell death through mitochondrial 
cascade in U937 cells. (Sikriwal et al., 2008). Horrix and co-workers demonstrated that 
low doses of ricin, volkensin and riproximin were able to induce the apoptotic pathway 
through activation of unfolded protein response (UPR) genes independently of protein 
synthesis inhibition (Horrix et al., 2011).  
In addition to the inhibition of translation, alternative mechanisms were proposed to 
explain how RIPs induce apoptosis. 
By damaging rRNA, RIPs are capable of activating the ribotoxic stress response 
through activation of mitogen-activated protein kinases (MAPKs) leading to apoptosis. 
The first evidence was in 1997 when ricin, α-sarcin and anisomycin showed the ability 
to induce the activation of SAPK/ JNK and p38 MAPK in response to specific signaling 
from damaged 28S rRNA and not simple related to protein synthesis inhibition 
(Iordanov et al., 1997). How cells detect damaged 28S and trigger signalling through 
the ribotoxic stress response is still unclear. Mutant shiga toxin 1 lacking RNA N-
glycosidase activity, prevented phosphorylation of p38 MAPK and consequently 
apoptosis in intestinal epithelial cells (HCT). On the contrary, the inhibition of p38 
MAPK and JNK activation in HCT cells were able to prevent cell death. Ricin even 
showed to trigger a similar ribotoxic stress response in the macrophage cell line RAW 
264.7 (Smith et al., 2003). Blocking of p38 MAPK resulted in the inhibition of TNF-α 
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release, culminating in apoptosis. This behavior was seen even with modeccin (Higuchi 
et al., 2003). 
Another mechanism proposed to RIP-induced apoptosis is the endoplasmic reticulum 
(ER) stress and the consequent unfolded protein response (UPR). ER is the intracellular 
organelle responsible for the correct folding and maturation of newly synthesized 
secretor and transmembrane proteins. Perturbations in the normal functions of the ER, a 
process named “ER-stress”, trigger UPR, which acts by arresting protein translation and 
transcription of genes to restore ER function. If ER dysfunction is severe or prolonged, 
UPR activates apoptotic signaling cascade. The activator of UPR is the chaperone 
BiP/Grp78. The presence of an overwhelming load of misfolded proteins induced Grp78 
dissociation from its conformational binding state of the transmembrane receptor 
PERK, IRE1 and ATF6, allowing them to become active. The activated PERK 
phosphorylates the eIF2α (eukaryotic translation initiation factor 2α), inhibiting 
translation with consequent growth arrest and promoting the transcription of activating 
transcription factor 4 (ATF4). Activated ATF6 translocates to the Golgi to activate UPR 
and ERAD genes, including the transcription factor XBP-1 (X-box binding protein 1), 
whose mRNA is alternatively spliced by IRE-1 and the resulted product upregulates 
UPR “stress genes” by directly binding to stress element promoters in the nucleus 
(Yadav et al., 2014). Human adenocarcinoma cell lines MDA-MB-231 and HCT116 
treated with type 2 RIPs were shown to activate genes connected with the UPR. The 
overexpression of these genes was regulated in a dose dependent manner after RIP 
treatment and suggested that RIPs induced ER stress, with subsequent apoptosis (Horrix 
et al., 2011). Also shiga toxin 1 was able to induce activation of the ER stress sensors 
IRE1, PERK and ATF6 in human monocytic cells, culminating in apoptosis (Lee et al., 
2008). 
Another mechanism proposed to induce apoptosis is by increasing of the reactive 
oxygen species (ROS) and by interaction with anti-oxidant proteins. Trichosanthin was 
shown to induce ROS production in human choriocarcinoma cells (JAR cells) after its 
interaction with a membrane-bound receptor. Intracellular calcium levels were shown to 
increase in parallel with ROS levels, suggesting that ROS production in trichosanthin-
treated cells might be a consequence of calcium signaling (Zhang et al., 2001). U937 
cells treated with mistletoe lectin II (MLII) displayed an increased levels of hydrogen 
peroxide, which activated the intracellular stress signaling and JNK/SAPK pathways, 
culminating in apoptosis; in the same study the treatment with a ROS scavenger was 
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successful in rescue the cells from apoptosis (Kim et al., 2003). Abrin was shown to 
induce an increase in ROS levels in U937 cells (Bhaskar et al., 2008); the treatment 
with the ROS scavengers N-Acetyl-l-cysteine (NAC) and Trolox gave a significant 
protection in abrin-treated Jurkat cells (Saxena et al., 2014). The treatment with ROS 
scavengers in neuroblastoma cells (NB100) treated with stenodactylin showed strong 
protective effects, saving the cells from death and allowing the survival of 75–100% of 
cell population (Polito et al., 2016a). 
Abrin was also found to directly interact with antioxidant protein-1 (AOP-1), which is 
located in the mitochondria protecting them from the action of ROS. The antioxidant 
activity inhibition of AOP-1 induced by abrin determined the increase of intracellular 
ROS, with a consequent release of cytochrome c from the mitochondria to the cytosol 
and activation of caspase-9 and caspase-3 (Shih et al., 2001). 
Apoptosis induced by the binding of the B-chain to cell receptors represents a further 
mechanism proposed for RIPs intoxication. In ricin-treated U937 cells the B-chain 
induced DNA fragmentation and morphological changes that are typical of apoptosis at 
a concentration that did not inhibit protein synthesis (Hasewaga et al., 2000). Sambucus 
nigra agglutinins II (SNAII), which consist only of the carbohydrate-binding B-chains, 
produced caspase-dependent apoptosis in sensitive midgut CF-203 cells at low 
concentration (Shahidi-Noghabi et al., 2010). 
An alternative apoptotic pathway induced by RIPs could be connected to their DNase 
activity. Several RIPs, such as ricin, cinnamomin, gelonin, saporin-6 and dianthin 30 
were shown to introduce specific cleavages into supercoiled DNA (Ling et al., 1994; 
Roncuzzi and Gasperi-Campani, 1996; Brigotti et al., 2002). Studies on saporin mutant 
showed that this toxin possessed both RNA glycosidase and genomic DNA 
fragmentation activity (Bagga et al., 2003). The evidenced nuclear localization of 
saporin-6 in HeLa cells suggested that one cell death mechanism induced by the toxin 
could be DNA damage (Bolognesi et al., 2012). 
It was also observed that the induction of apoptotic cell death might be caused by RIPs 
even when they are constituents of immunotoxins (Bolognesi et al., 1996; Polito et al., 
2009a). 
In addition to apoptosis, the involvement of alternative cell death pathways elicited by 
RIPs were described. Both caspase-dependent and independent cell death mechanisms 
have been described for several RIPs. Interestingly, a same toxin can cause more than 
one death mechanism. For example, in Jurkat cells treated with abrin caspase-dependent 
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apoptosis was evidenced (Narayanan et al., 2005). Instead, in human B cell line 
(U266B1) treated with the same toxin, an increase of ROS levels and lysosomal 
membrane permeabilization were found, whereas apoptosis and caspase activation were 
not observed. The authors hypothized the involvement of caspase-independent 
programmed necrosis (Bora et al., 2010). In human Hodgkin’s lymphoma cell line 
(L540) treated with saporin and ricin, Polito and co-workers proposed a mechanism of 
cell death that is partially independent of both caspase activation and necrosis (Polito et 
al., 2009a). The same group demonstrated that stanodactylin can induce multiple cell 
death pathways, which involve mainly apoptosis, but also necroptosis and the 
production of free radicals (Polito et al., 2016a). 
Finally, these data confirmed that RIPs clearly inhibit protein synthesis. Despite several 
studies have been conducted in order to elucidate the mechanism through which RIPs 
trigger apoptosis, many questions remain still unclear. 
1.2.6 Antiviral activity 
Type 1 and some type 2 RIPs have been shown to possess antiviral activity against 
plants, fungal and animal viruses. The discovery of the antiviral properties of RIPs dates 
back to 1925, when Duggar and Armstrong demonstrated that leaf extract of Phytolacca 
Americana gave antivirus protection to tobacco plant (Duggar and Armstrong, 1925). 
After 50 years, the antiviral factor was extracted and called PAP (Pokeweed Antiviral 
Protein) (Irvin, 1983). Subsequently, many RIPs were shown to possess antiviral 
activity against plant viruses (Lodge et al., 1993), fungi (Vivanco et al., 1999), bacteria 
and animal viruses (Zhou et al., 2000). The exact mechanism of RIP antiviral activity is 
still not completely understood. 
Initially it was thought that RIPs interacted with plant ribosomes of the infected cells, 
inactivating them with consequent death of the cells and block of viral replication 
(Fernández-Puentes and Carrasco, 1980). Afterwards, thanks to recombinant techniques, 
mutated RIPs showed that the ribosome inactivation is not directly involved in antiviral 
activities and it was suggested that the mechanism of action of RIP consists in the direct 
deadenylation of viral nucleic acid (Barbieri et al., 1997, Stirpe et al., 2006). For 
example, PAP mutants expressed in transgenic tobacco plants, show protection against 
potato virus X (Tumer et al., 1997) and fungal pathogen (Zoubenko et al., 1997); other 
PAP mutants are able to depurinate HIV-1 RNA (Uckun et al., 2003). PAP also show to 
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inhibit the production of human T-cell leukemia virus 1 (HTLV-1) (Mansouri et al., 
2009). In agriculture, the role of plant defense displayed by RIPs allowed to create 
transgenic plants resistant to infection by microorganisms. For example, the expression 
of PAP or trichosanthin protects the plant of tobacco from viral infections, though 
causing an altered phenotype (Lodge et al., 1993). The separation of the antiviral 
function from enzymatic activityhas been possible by creating mutants able to protect 
the plant, leaving the phenotype unaltered (Tumer et al., 1997). Thanks to anti-fungal 
properties of RIPs, even transgenic tobacco plants resistant to infections by fungi have 
been created with success (Tumer et al., 1999). Many other plants have been transfected 
with RIP genes, mainly with PAP, trichosanthin, dianthin and barley RIP (Dowd et al., 
2003; Rosenblum, 2004). RIPs have been shown to inhibit also animal viruses, for 
example blocking the viral replication of influenza virus (Tomlinson et al., 1974), 
poliovirus, herpes simplex virus (Foà-Tomasi et al., 1982) and HIV virus (Zarling et al., 
1990). 
1.3 Toxic and non-toxic type 2 RIPs 
1.3.1 Type 2 toxic RIPs from Adenia 
Adenia genus belonging to Passifloraceae family includes about 100 species that are 
restricted to the tropics and subtropics, with centers of diversity mostly in Africa, in 
particular in Madagascar, and in Asia. The genus is characterized by conspicuous leaf 
glands present in the majority of species, from which the genus derives its name (Hearn, 
2006). Adenia genus include trees, bushes, grasses, vines and lianas and it is adapted to 
several habitats, from the desert of Namibia coasts to the rainforest of South Asia. The 
elder plants have been used since ancient times, especially in traditional African 
medicine (Akendengue et al., 2005). Many Adenia plants are known to contain potent 
poisons. For example, Adenia lobata is used in Nigeria to treat respiratory disorders, 
syphilis, gonorrhea and nose cancer (Gill, 1992; Osuagwu and Ibeabuche, 2010), 
whereas in Ghana it is used for the treatment of diabetes mellitus (Mshana et al., 2000). 
Adenia cissampeloides is used in Zimbabwe for the prevention of malaria (Talkmore et 
al., 2015) and for the treatment of many diseases, such as gastro-intestinal and liver 
disorders, anemia, venereal diseases, parasitic infections, pain, depression and madness 
(Schmelzer and Gurib-Fakim, 2008). Moreover, some Adenia species were found to 
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contain several bioactive constituents. A. lobata contains several phytochemicals 
compounds with therapeutic benefits such as alkaloids, steroidal glycosides, saponins, 
flavonoids and tannins (Agoreyo et al., 2012). In addition, it also shows anti-
hyperglycaemic and antioxidant activity. The presence of phytochemical constituents 
similar to those of A. lobata is probably responsible of in vitro anti-plasmodic properties 
of A. cissampeloides (Talkmore et al., 2015). 
Some of the highly toxic type 2 RIPs were identified in Adenia species: modeccin from 
the roots of A. digitata (Barbieri et al., 1980) and volkensin from the roots of A. 
volkensii (Barbieri et al., 1984) were the first to be extracted; more recently A. goetzii 
lectin, lanceolin and stenodactylin were purified from the caudices of A. goetzii, A. 
lanceolata and Adenia stenodactyla (Stirpe et al., 2007) (table 1.3). Type 2 RIPs 
extracted from Adenia genus are the most potent plant toxins known, able to irreversibly 
inhibit protein synthesis and to induce death in cells and in animals at very low doses. In 
particular, stenodactylin is considered the most potent plant toxin known for its  toxicity 
both in cell cultures and in experimental animals. The peculiarity of Adenia toxins is the 
ability to be transported in a retrograde manner not only along peripheral nerves, such 
as ricin and abrin, but also within the central nervous system. (Wiley and Stirpe, 1988; 
Monti et al., 2007). This property could have different medical and biotechnological 
applications in the field of neuroscience to selectively lesion specific neurons, i.e. in 
behaviour studies.  
Adenia RIPs show an intracellular pathway very similar to that of ricin (see section 
1.1.4). Their high cytotoxicity has been explained by their high affinity binding to the 
cell and efficient endocytosis, intracellular routing, partial resistance to proteolysis, and 
high accumulation into the cell especially in the case of stenodactylin. Lanceolin and 
stenodactylin have a higher uptake than that of volkensin (Battelli et al., 2010). In 
addition, after binding to the cell membrane, they do not require the endosomal 
acidification to enter the cell, but the routing through the Golgi is essential for them. 
However, modeccin can reach the cytosol either by endosome acidification or by the 
involvement of nigericin (Ghosh and Wu, 1988). 
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Table 1.3. RIPs and lectins purified from Adenia species. (A) IC50 values for the single A-chain, 
obtained under reducing conditions (Schrot et al., 2015). 
Proteins Species Tissues IC50 
Type 2 RIPs    
Modeccin = Modeccin 4B 
A. digitata 
roots 4 µg/mL; 66 ng/mL (A)  
Modeccin 6B roots 0.31 µg/mL 
Adenia goetzei lectin A. goetzei caudex 55.1 µg/mL; 0.7 µg/mL (A) 
Lanceolin A. lanceolata caudex 5.2 µg/mL; 1.1 µg/mL (A)  
Stenodactylin A. stenodactyla caudex 5.6 µg/mL; 0.5 µg/mL 
Volkensin A. volkensii roots 5 µg/mL; 0.37 nM (A) 
Type 2 RIPs candidate    
Adenia ellenbeckii lectin A. ellenbeckii caudex 10.1 µg/mL; 1.2 µg/mL (A) 
Adenia glauca lectin A. glauca caudex >10 µg/mL; >5 µg/mL (A) 
Adenia keramanthus lectin A. keramanthus caudex 10.0 µg/mL; 1.1 µg/mL (A) 
Adenia spinosa lectin A. spinosa caudex 4.7 µg/mL; 0.8 µg/mL (A) 
Adenia venenata lectin A. venenata caudex 2.4 µg/mL; 0.4 µg/mL (A) 
Lectins    
Adenia fruticosa lectin A. fruticosa caudex >100 µg/mL 
Adenia racemosa lectin A. racemosa caudex >400 µg/mL 
 
1.3.2 Non-toxic type 2 RIPs from Sambucus 
Sambucus genus, belonging to Adoxaceae family, includes shrubs and small trees 
spread in Europe, Asia, America and Africa (Tejero et al., 2015). The elder plants have 
been used since ancient times, in particular by Romans for medicinal purposes. S. nigra 
berries have been widely used over the centuries in Europe for the treatment of a wide 
range of common problems, such as toothache, for ear and eye problems, wounds, skin 
burns, colics, dysentery, arthritis, rheumatism, fever, epilepsy, and other diseases. 
(Tejero et al., 2015; Polito et al., 2016b). The remains of seeds and charcoal of S. 
ebulus, S. nigra and S. racemosa, dating back to the Neolithic and Chalcolithic (Copper 
Age), have been found in archaeological excavations. It is possible that population sof 
northern Italy (Mariotti-Lippi et al., 2010) and southern France (Martin et al., 2008) 
used the wild elderberry as a complement to cereals. 
Sambucus genus consists of about 20 species from which several RIPs were extracted, 
both type 1 and type 2, and lectins, which can be produced simultaneously in different 
tissues or in the same tissue of the same plant (table 1.4). The amount of protein 
expressed in a specific tissue can vary with the development of the plant and during the 
seasons. For example, ebulin l, extracted from the leaves of S. ebulus, is present in 
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young plants in higher level than those of SELld lectin; with the development of the 
plant, the level decrease and disappear during senescence, whereas lectin level increase 
(Rojo et al., 2003). Nigrin b, extracted from the bark of S. nigra, is highly expressed in 
spring and summer (Ferreras et al., 2010). 
Sambucus RIPs, both type 1 and type 2, are able to depurinate rRNA and to inhibit 
protein synthesis in a cell-free system constituting of a rabbit reticulocytes lisate with 
IC50 in the order of nM (Girbes et al., 1993a, b). Type 2 RIPs from Sambucus showed a 
low cytotoxicity, comparable to that of type 1 RIPs, even though they are endowed with 
lectin activity and are able to strongly inhibit protein synthesis in cell-free systems. For 
example, the IC50 values in HeLa cells treated with ebulin l and nigrin b were 64.3 and 
27.6 nM, respectively, with respect to 0.67 pM observed with ricin (Citores et al., 
1996). Toxicity of Sambucus RIPs was also tested in mice, showing a LD50 of 2 and 12 
mg/kg for ebulin l and nigrin b, respectively, with respect to 0.003 mg/kg observed with 
ricin (Girbes et al, 1993b).  
The low toxicity of non-toxic type 2 RIPs could be due to an inefficient translocation 
through the plasma membrane or to different intracellular modifications that do not 
allow them to reach the ribosomes. The interaction of nigrin b and the highly toxic type 
2 RIP volkensin with HeLa cells was compared, both showing a similar binding affinity, 
but lower than that of ricin. This result suggested that the low cytotoxicity of nigrin b 
might depend on a different intracellular pathway with respect to toxic type 2 RIPs. 
After internalization into the endosomes, nigrin b is rapidly degraded into the lysosomes 
and then exocytosed. All nigrin b excreted is totally inactive, whereas a percentage of 
toxic type 2 RIPs remain active after exocytosis and can be recycled (Battelli et al., 
2004). Nigrin b was found to bind different glycoproteins on the plasma membrane and 
utilize a different intracellular routing than ricin. Moreover, inhibition of protein 
synthesis by nigrin b seems to be a consequence of the spontaneous translocation of the 
RIP from the endosome to the cytosol, which occurs when the concentration of the toxin 
is high, so that it can reach the ribosomes (Ferreras et al., 2011). 
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Table 1.4. RIPs and lectins purified from Sambucus species.(Ferreras et al., 2011). 
 
Proteins Species Tissues 
Type 1 RIPs   
Ebulitins α, β, γ S. ebulus Leaves 
Nigritins f1, f2 S. nigra Fruits 
Heterodimerictype 2 RIPs   
Ebulin l S. ebulus Leaves 
Ebulin f S. ebulus Fruits 
Ebulin r1, r2 S. ebulus Rhizome 
Nigrin b, basic nigrin b, SNA I’, 
SNLRPs S. nigra Bark 
Nigrin l1, l2 S. nigra Leaves 
Nigrin f S. nigra Fruits 
Nigrin s S. nigra Seeds 
Sieboldin b S. sieboldiana Bark 
Basic racemosin b S. racemosa Bark 
Tetramerictype 2 RIPs   
SEA S. ebulus Rhizome 
SNA I S. nigra Bark 
SNAIf S. nigra Fruits 
SNAflu-I S. nigra Flowers 
SSA S. sieboldiana Bark 
SRA S. racemosa Bark 
Monomericlectins   
SELlm S. ebulus Leaves 
SEA II S. ebulus Rhizome 
SNA II S. nigra Bark 
SNAlm and SNAIVl S. nigra Leaves 
SNA IV S. nigra Fruits 
SNA III S. nigra Seeds 
SSA-b-3 and SSA-b-4 S. sieboldiana Bark 
SRAbm S. racemosa Bark 
Monomericlectins   
SELld S. ebulus Leaves 
SELfd S. ebulus Fruits 
SNAld S. nigra Leaves 
 
Studies on the amino acid sequences and a comparison with toxic type 2 RIPs revealed 
that ebulin l share a homology with ricin A-and B chains of 34% and 48%, respectively 
(Pascal et al., 2001). X-ray diffraction analysis showed that ebulin l have an overall 
folding similar to ricin, but different galactose binding properties. In ricin, both 1α and 
2γ subdomains bind galactose and lactose; instead, in ebulin l only 1α subdomain bind 
both galactose and lactose in a similar way to ricin, whereas 2γ site is able to bind only 
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the galactose, but differently from ricin. The orientation and the positioning of galactose 
within the binding cleft are different and this probably causes steric interference. This 
could be responsible of the weaker interaction with cells, thus of the low citotoxicity of 
ebulin l (Ferreras et al., 2010). 
Thanks to their high enzymatic activity and less non-specific toxicity, the non-toxic type 
2 RIPs ebulin l and nigrin b have been used in preclinical studies in order to reduce the 
toxic side effects, which are characteristic of the RIP-based therapy. In particular, two 
immunotoxins have been constructed: the first one directed towards the transferrin 
receptor, which is highly expressed in some cell lines and in many human tumors 
(Citores et al., 2002); the second one specific for the endothelial receptor CD105 
(endoglin), which is strongly expressed during neoangiogenesis and in vessels of tumor 
tissues (Benítez et al., 2005; Muñoz et al., 2007). These immunotoxins showed high 
cytotoxicity with IC50 value in the picomolar range.  
Moreover, mice treated with an intravenous injection of a lethal dose of nigrin b (16 
mg/kg), showed intestinal lesions and the disappearance of the intestinal villi and crypts. 
Sub-lethal doses (5 mg/kg) of the toxin induced the complete recovery of the normal 
functions nine days after the injection. In particular, apoptotic changes were observed in 
highly proliferating stem cells of the intestinal crypts (Gayoso et al., 2005). Recently, 
these apoptotic changes were also observed in mice treated with ebulin l (Jiménez et al., 
2013). 
1.4 RIP employment in experimental and clinical medicine  
1.4.1 Immunotoxins 
In the medical field, RIPs have been studied for their antitumor activity. Since 1970, 
several studies evidenced that the toxicity of RIPs, especially ricin, was higher toward 
cancer cells compared to healthy cells (Lin et al., 1970; Fodstad et al., 1977). This 
effect is probably due to the higher permeability of the membrane of neoplastic cells 
compared to that of normal cells, determined by changes in the lipid and protein 
composition of the tumor cell. Although possessing an efficient cell killing mechanism, 
they lack selectivity toward cell targets necessary for the therapeutic use. Most of the 
interest in RIPs in the biomedical field is the possibility of directing them in a selective 
manner against undesired or harmful cells. This was achieved by linking them to 
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carriers to obtain conjugates, which specifically recognize antigens or receptors that are 
expressed on the membrane surface of the targeted cells. These conjugates are defined 
immunotoxins (ITs) and can be useful to treat cancer and also immunological disorders 
(Madhumathi and Verma, 2012). The carriers used for conjugation include hormones, 
growth factors, cytokines, interleukins, antigens and vitamin-binding proteins, but 
monoclonal and polyclonal antibodies seem to be the most powerful (Bolognesi and 
Polito, 2004). ITs can be obtained by chemically conjugation of the toxin to an antibody 
or antibody fragment. It is necessary that the two moieties be conjugated via covalent 
bond stable in the extracellular environment, in order to allow IT to exert its action. 
However, this bond has to be reversible, so that it can easily be broken once IT is 
internalized into the cell. The most used chemical bond for this purpose is the disulfide 
bridge between cysteine residues, which may be already present in the toxin or 
chemically inserted. The resulting product is stable but heterogeneous and often not 
suitable for clinical practice. New generation Its are synthesized using recombinant 
DNA techniques, in which the gene encoding an antibody fragment is fused with the 
gene encoding a modified toxin. The production of these ITs could be achieved using 
different expression hosts, such as bacteria (Wang et al., 1997), yeasts (Lombardi et al., 
2010) and algae (Mayfield, 2013), resulting in the production of a single-chain fusion 
protein. After binding of the antibody moiety to the target cell surface, IT is internalized 
through the endocytic compartment. In the endosome, the bond between antibody and 
toxin is reduced, allowing the toxin moiety to reach the cytosol and exert its enzymatic 
activity. Both type 1 and type 2 RIPs have been used for the construction of IT. Saporin, 
abrin and especially ricin are among the most used. Type 2 RIPs are highly toxic, but 
have the disadvantage of non-specific cell binding of the B-chain. Different strategies 
have been proposed, such as the use of: (i) modified or blocked B-chain; (ii) isolated 
and/or deglycosylated A chain; (iii) type 1 RIPs and (iiii) non-toxic type 2 RIPs (e.g., 
ebulin l and nigrin b) as toxic part of IT (Stirpe, 2004). Also many type 1 RIPs have 
been employed to construct ITs and in some cases type 1 RIP-containing ITs resulted 
more active than those containing RTA (Siena et al., 1988; Bolognesi et al., 1992). In 
fact, type 1 RIPs have the advantage of being less dangerous, more stable and easy to 
prepare with respect to type 2 RIPs. Saporin-S6 is the most utilized type 1 RIP for the 
construction of ITs (Polito et al., 2011; Polito et al., 2013). In particular, saporin-S6 
containing ITs were largely used in neuroscience studies for selectively destroying 
neurons (Wiley, 2008; Bolognesi et al., 2016). 
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The best results in IT-based therapy were obtained in haematological field, both in 
cancer therapy and against autoimmune immunological disorders. 
1.4.2 Anti-tumor therapy 
To date, several immunotoxins containing type 1 or the A-chain of type 2 RIPs have 
shown encouraging results in numerous pre-clinical models (Fracasso et al., 2010) and 
clinical trials (Polito et al., 2011; Palanca-Wessels et al., 2014), with the best results in 
the experimental treatment of hematological malignancies (Dosio et al., 2014). The cell-
killing efficiency of ITs mainly depends on the cell type, antigen availability, binding 
affinity and intracellular routing. RTA or blocked ricin were used in patients with B- 
and T-cell leukemia and lymphomas (Bolognesi and Polito, 2004), whereas ITs 
containing saporin conjugated to an anti-CD30 or anti-CD22 monoclonal antibody were 
used for the treatment of patients with Hodgkin’s and non-Hodgkin’s lymphoma, 
respectively (Polito et al., 2011). Several clinical trials based on RIP-containing ITs are 
underway. Despite the encouraging results, several limitations have been reported; 
among them the poor penetration of the conjugates into solid tumors, side effects, such 
as vascular leak syndrome (VLS) and hepatotoxicity, and immunogenicity (Stirpe, 
2004). 
The poor penetration into solid tumors can be overcome by the employment of smaller 
conjugates, such as antibody fragments (scFv) or using ITs against the endothelial cells 
of tumor blood vessels, resulting in thrombosis and consequent ischemia of the tumor 
(Stirpe, 2004). 
VLS is caused by an endothelial damage, which induce an increase of vascular 
permeability and it is characterized by weight gain, edema, hypoalbuminemia, 
hypotension and sometimes dyspnea (Pincus et al., 2011). It has been proposed that 
VLS is due to short amino acid motifs of the toxin, which interact with integrins 
localized on endothelial cells, favoring the internalization of the toxin with consequent 
cell death (Baluna et al., 2000). Modification or deletion of these sequences were shown 
to be effective in reducing toxin-induced VLS (Wang et al., 2007; Weldon et al., 2013). 
Instead, liver toxicity seems to be a multifactorial event and to depend on the type of 
toxin that is used (Battelli et al., 1994). 
One of the main problems in the clinic use of ITs in is the onset of the immune 
response, which does not allow a repeated administration of the conjugate, except for 
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immunodeficient patients. The immunogenicity can be overcome by using ITs with 
partially or fully humanized antibodies (Hoogenboom et al., 1992). Several 
immunosuppressive treatments were performed in order to reduce IT-associated 
immune response, even if with poor results (Alewine et al., 2015). Moreover, a therapy 
with alternation of ITs containing different toxins could avoid the immune response 
against the toxin moiety.  
Other strategies have been proposed in order to enhance the toxicity of ITs. The use of 
tenside-like compounds, such as saponins, in combination with ITs was found to 
enhance endosomal escape (Gilalbert-Oriol et al., 2014). Moreover, the employment of 
photochemical internalization (PCI) technology was found to be very efficient. PCI is 
based on the activation by light of photosensitizers located in endocytic vesicles, 
causing a controlled membrane breakage with consequent release of molecules from the 
endocytic vesicles. As ITs enter cells by receptor-mediated endocytosis, PCI could 
allow the release of the toxin inside the tumor (Weyergang et al., 2011). 
1.4.3 Immune disorders 
ITs have been used also for autoimmune diseases. The first IT used in clinical trials was 
the anti-CD5/RTA for the treatment of rheumatoid arthritis, systemic lupus 
erythematosus and insulin-dependent diabetes mellitus (Strand et al., 1993; Stafford et 
al., 1994; Skyler et al., 1993). One approach was to conjugate the RIP with antigens 
responsible for the disease in order to directly interact with the immunocompetent cells. 
Tetanus toxoid conjugated to ricin was able to eliminate specific antibody-producing B-
cell clones, leaving intact the remainder of the B-cell repertoire (Volkmann et al., 
1982). RTA was also conjugate to human thyroglobulin for the treatment of patients 
with Hashimoto disease (Rennie et al., 1983). Glennie and co-workers evaluated ITs 
consisting of monoclonal anti-idiotype conjugated to saporin in the treatment of guinea 
pig B lymphocytic leukemia. The immunoglobulin-secreting leukemic cells were 
selectively eliminated (Glennie et al., 1987). Two ITs were used for the treatment of 
AIDS, using the type 1 RIP PAP: one directed against the viral antigens expressed on 
the surface of infected cells and the second able to recognize antigens on CD4+ 
lymphocytes, in which the virus replicates (Pincus, 1996). Good results were obtained 
in specific suppression of immune response to acetylcholine receptor. ITs containing 
antibody against the nicotinic acetylcholine receptor and RIP were used for the 
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treatment of focal muscle spam (Hott et al., 1998) and strabismus by destroying 
oculomotor muscle (Christiansen et al., 2002). Moreover, a fusion protein composed of 
a portion of the extracellular domain of the nicotinic acetylcholine receptor and the type 
1 gelonin was used in the experimental treatment of myasthenia gravis. (Hossann et al., 
2006). 
RIPs have been also used for the prevention and control of transplant rejection and 
graft-versus host disease (GVHD). Ricin-containing ITs against antigens on mature T 
lymphocytes have been evaluated both in vitro and in vivo studies (Vallera, 1982; 
Vallera, 1983). Even ATG-saporin-S6 (Polito et al., 2009b) and CTLA-4-saporinS6 
(Tazzari et al., 2001) were used for this purpose. 
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Kirkiin: a new toxic type 2 
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AIM OF THE PROJECT 
Type II RIPs are the most potent plant toxins known, able to irreversibly inhibit protein 
synthesis and to induce death in cells and in animals at very low doses. They were 
identified only in a few plant species, differently from type 1 RIPs that have been 
discovered in many plants belonging to different families, even phylogenetically 
unrelated. Until now, approximately 84 type 2 RIPs have been purified in a few genera 
(Sambucus, Aralia, Polygonatum, Cucurbita, Momordica, Hura, Ricinus, Abrus, 
Adenia, Iris, Cinnamomum, Ximenia, Adenia, Erantis, Phoradendron and Viscum). In 
particular, those extracted from plants belonging to the Adenia genus are among the 
most powerful plant toxins identified. In addition to modeccin and volkensin, extracted 
from the roots of Adenia (Modecca) digitata and Adenia volkensii, respectively 
(Barbieri et al., 1993), that are known from many years, other two potent toxins from 
the caudices of Adenia lanceolata (lanceolin) and Adenia stenodactyla (stenodactylin) 
were more recently described (Stirpe et al., 2007). The high cytotoxicity of Adenia RIPs 
is probably due to their high affinity cell binding, efficient endocytosis and intracellular 
routing, resistance to proteolysis, and, regarding stenodactylin, high accumulation into 
the cell (Battelli et al., 2010). 
Adenia toxins are the only type 2 RIPs retrogradely transported along peripheral nerves 
and in the central nervous system (Wiley & Kline IV, 2000; Pelosi et al., 2005; Monti et 
al., 2007). This property has different medical and biotechnological applications in the 
field of neurophysiology and for the experimental treatment of pain. Moreover, because 
of their high cytotoxicity, these proteins could be used for pharmacological purpose, 
both native, for local-regional treatments, and as components of immunotoxins, for 
systemic treatments. These properties prompted us to evaluate whether other species 
belonging to Adenia genus, contain lectins or RIPs structurally similar to others already 
purified from the same genus, and possibly endowed of peculiar biological properties. 
In this study, the presence of galactose-binding lectins was investigated in the caudex 
of four plants belonging to Adenia genus (Passifloraceae family), namely: A. epigea, 
A. monodelpha, A. lindenii and A. kirkii. All plants contain lectins that are able to 
agglutinate human erythrocytes in a range between 4-8 µg/ml. The lectins from A. 
lindenii and A. kirkii had the highest cytotoxicity. In particular, that from A. kirkii, 
named kirkiin, showed strong ability to inhibit cell protein synthesis, with a 
cytotoxicity comparable to that of stenodactylin. This prompted us to further deepen 
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the study of this protein, with particular regard to its biochemical, enzymatic and 
cytotoxic properties, and to its three-dimensional structure. 
The name Adenia kirkii was given by Heinrich Gustav Adolf Engler in 1891 to a 
member of Passifloraceae family, spread in Kenya, eastern Tanzania and Zanzibar. The 
word “aden” derives from the greek and means gland, as these plants have typical 
glandular-shaped leaves, and “kirkii” derives from Thomas Kirk (1828-1898) a famous 
botanical of New Zealand (Eggli and Newton, 2013). The plant has green flowers, 
narrow and lobed leaves and a caudex as reserve organ, situated at the base of the plant; 
it can reach a height of 3 meters and a caudex up to 30 cm in diameter (figure 1). 
 
 
 
Fig. 1.: Adenia kirkii. 
 
In order to clarify the pathogenetic mechanisms of kirkiin intoxication, inhibition of 
protein synthesis and loss of cell viability were evaluated. As many studies showed that 
RIPs induce apoptosis in several cell systems (Bolognesi et al., 1996), the involvement 
of apoptotic mechanism was clarified. The study was focused especially on cells of 
nervous origin for their known high sensitivity to RIPs and for the possible use of 
kirkiin in neurophysiological studies. In addition, structural and enzymatic 
characterization of the new toxin was performed in collaboration with Prof. Ferreras at 
the University of Valladolid. The amino acid sequence of kirkiin was determined and a 
comparison with the sequences of other type 2 RIPs (toxic and non-toxic) was 
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performed, in order to provide useful information about the amino acids that are directly 
or indirectly involved in kirkiin toxicity. A three-dimensional structure was also 
predicted. Knowledge about the amino acid sequence associated with the structure 
analysis of the RIP is essential in understanding the protein function and to correlate 
structural differences among RIPs to their different cytotoxic mechanisms.  
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RESULTS AND DISCUSSION 
2.1 Partial purification and characterization of Adenia lectins 
Caudices of A. epigea, A. lindenii, A. monodelpha and A. kirkii were processed as 
described in section 4.2.1. The extracts were subjected to chromatography on an acid 
treated Sepharose CL-6B column, and the lectins were eluted with 0.2 M galactose. On 
gel electrophoresis (figure 2.1) the unreduced proteins from A. epigea and A. lindenii 
gave one main band with apparent molecular weight (Mw) of 30 kDa approximately. 
The lectins from A. monodelpha gave two main bands with Mw 32 kDa and 34 kDa and 
one band with Mw >66 kDa approximately. Under non-reducing conditions the 
electrophoretic pattern did not change. The unreduced lectins from A. kirkii gave two 
main bands with apparent Mw 32 kDa and 60 kDa, approximately. After reduction, A. 
kirkii showed three bands with Mw 28 kDa, 31 kDa and 35 kDa approximately. 
 
 
Fig. 2.1. SDS-PAGE of Adenia lectins. The molecular weights are expressed in kDa. The 
electrophoresis was carried out on 20% homogeneous gel of polyacrylamide (staining with 
Coomassie Blue). Lectins from A. epigea (lane 1), A. monodelpha (lane 2), A. lindenii (lane 3) 
and A. kirkii (lane 4) were analysed under unreduced (left) and reduced (right) conditions. 
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The purified proteins from all plants were assayed for the inhibition of protein synthesis 
by a rabbit reticulocyte lysate (table 2.1). The A. kirkii lectins showed the highest 
translational inhibiting activity, with IC50 values of 7.44 and 3.78 µg/ml for the 
unreduced and reduced protein, respectively. The lectin from A. lindenii exhibited IC50 
values of about 37 µg/ml, whereas the lectins from A. monodelpha and A. epigea 
showed a weak inhibition activity. All the lectins had agglutinating activity for human 
erythrocytes (table 2.1). The presence of agglutination was indicated by an uniform 
coating of the bottom of the well by erythrocytes, while the absence of agglutination 
was indicated by a red button of erythrocyte sedimentation on the bottom of the 
microtiter plate surrounded by a concentric clear zone. The minimum lectin 
concentration causing agglutination ranged from 4.02 to 8.12 µg/ml.  
Therefore, the lectins from A. lindenii and A. kirkii showed the highest toxicity. In 
particular, those from A. kirkii showed strong ability to inhibit cell protein synthesis, 
with a toxicity comparable to stenodactylin, the most potent cytotoxic type 2 RIP. This 
prompted us to deepen the study of the toxins from A. kirkii. 
Table 2.1. Biological activities of proteins purified by affinity chromatography. 
Adenia species Inhibitory activity on protein 
synthesis (cell-free) Haemagglutinating activity 
 
Rabbit reticulocyte lysate IC50 
(µg/ml) 
Minimum concentration causing 
agglutination (µg/ml) 
 
Unreduced 
protein 
Reduced 
protein  
A. monodelpha >100 60.7 5.06 
A. kirkii 7.44 3.78 4.02 
A. epigea >100 >100 4.59 
A. lindenii 37.1 37.6 8.12 
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2.1.1 Purification of A. kirkii lectins 
As described above, A. kirkii showed the presence of two lectins with different 
molecular weight, which strongly inhibited protein synthesis by a rabbit reticulocyte 
lysate system. As a consequence, a further purification procedure was undertaken in 
order to allow their separation. A peak of protein material was eluted by Sepharose CL-
6B; about 108 mg of total proteins with RIP activity were obtained from 100 g of fresh 
tissue. The yield was 13,1% (table 2.2). 
 
Table 2.2. Purification summary table. 
 
a
 Concentration of protein that inhibits the 50% of protein synthesis in unreduced conditions, measured by linear 
regression. 
b Units of IC50 in 1 mg of protein. 
c Specific activity multiplied the total mg of proteins. 
 
Subsequently, a chromatography step by gel filtration on Sephacryl S-100 was 
performed in order to separate the two lectins. The eluate from CL-6B (about 38 ml) 
was concentrated to 2 ml on YM-10 membrane under nitrogen pressure and then loaded 
into the column. Chromatography allowed the complete separation of the two lectins. 
As shown in figure 2.2, CL-6B peak was resolved into two peaks, the first one 
corresponding to the high molecular weight lectin and the second one to the low 
molecular weight lectin, with a yield of approximately 14 mg and 36 mg per gram of 
tissue, respectively (for more details see table 2.2). 
 
 
Preparation 
from caudex 
Protein 
(mg/ml) 
Total 
protein 
(mg) 
Total 
protein 
(%) 
IC50 
(µg/ml)a 
Specific 
activity 
(U/mg)b 
Total 
activity 
(U)c 
Yield 
(%) 
Crude extract 3,46 1730 100 55 18,2 31454,5 100 
CL-6B eluate 2,84 107,9 6,2 9,2 108,7 4130,4 13,1 
S-100 peak 1  1,43 24,2 1,4 11,1 90,1 2184,0 6,9 
S-100 peak 2 1,49 62,4 3,6 >50 - - - 
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Fig. 2.2. Chromatography by gel filtration on Sephacryl S-100 of CL-6B eluate. Proteins were 
separated on the basis of the different size and eluted in PBS.  
 
The fractions corresponding to each peak were collected and analyzed by SDS-PAGE 
on a 8-25% gradient gel in order to verify their purity (figure 2.3). Fractions 
corresponding to the high molecular weight lectin (lane 1) and fractions corresponding 
to the low molecular weight lectin (lane 4) were used for further analyses. 
 
 
 
Fig. 2.3. SDS-PAGE of S-100 fractions under non-reducing conditions. Lane 1 corresponds to 
the first peak; lane 2 corresponds to the tail of the first peak; lane 3 corresponds to the beginning 
of the second peak and lane 4 corresponds to the second peak. The electrophoresis was carried 
out on a 8-25% gradient polyacrylamide gel (staining with Coomassie Blue). Molecular weights 
of the standard are expressed in kDa. 
 
Electrophoretic analysis by SDS-PAGE on a 4-15% gradient gel was performed under 
reducing and non-reducing conditions. High molecular weight lectin revealed the 
presence of a single band with mobility corresponding to 58 kDa under non-reducing 
conditions (figure 2.4, lane 4). After reduction with 2-mercaptoethanol, two bands of 
about 27 kDa and 35 kDa were obtained (figure 2.4, lane 2). Based on the data reported 
in the literature, the A-chain of type 2 RIPs weights about 20-30 kDa, whereas B-chain 
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about 30-35 kDa (Stirpe, 2004). Therefore, we can assume that the two bands of 
approximately 27 and 35 kDa represent the A-chain and the-B chain of a type 2 RIP, 
respectively. The low molecular weight lectin showed only one band of about 32 kDa 
both in reducing and non-reducing conditions, compatible with a single-chain lectin 
(figure 2.4, lane 1 and lane 3, respectively). 
 
 
 
Fig. 2.4. SDS-PAGE of lectins under reducing and non-reducing conditions. Lane 1 and 2 
correspond to the reduced low molecular weight and high molecular weight lectins, 
respectively. Lanes 3 and 4 correspond to the unreduced low molecular weight and high 
molecular weight lectins, respectively. The electrophoresis was carried out on a 4-15% gradient 
polyacrylamide gel (staining with Coomassie Blue). Molecular weights of the standard are 
expressed in kDa. 
2.1.2 Enzymatic properties 
2.1.2.1 Effects on protein synthesis 
The effect of the purified lectins on mammalian ribosomes was evaluated in vitro in a 
cell-free system consisting of a lysate of rabbit reticulocytes, by assaying their 
inhibitory activity on protein synthesis through determination of the incorporation of L-
[4,5-3H]–leucine (figure 2.5). The two proteins were assayed both in native form and in 
reducing conditions, thus eliminating the possible steric hindrance given by B-chain. 
Double-chain lectin showed a strong inhibition of protein synthesis, displaying IC50 
values (concentration inhibiting 50% of protein synthesis) of 11.1 µg/ml in the native 
status and of 1 µg/ml under reducing conditions. These results were comparable to those 
obtained for other Adenia RIPs already studied, that showed IC50 values in the range of 
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0.4-1.2 µg/ml under reducing conditions and of 2.4-7.5 µg/ml under non-reducing 
conditions (Pelosi et al., 2005) (table 2.3). Therefore, these data suggested that the 
double-chain lectin purified from A. kirkii is a toxic lectin with RIP activity and the 
name of kirkiin was given to it. Instead, single-chain lectin revealed a very low 
inhibition activity with IC50 value greater than or equal to the maximum dose used (50 
µg/ml). As the single-chain lectin did not inhibit protein synthesis at the tested doses, 
we chose to continue the research only with the type 2 toxin kirkiin. 
 
 
 
 
Fig. 2.5. Inhibition of protein synthesis assay on a lysate of rabbit reticulocytes. Protein 
synthesis was determined by measuring the radioactivity incorporated by proteins. IC50was 
calculated by interpolation on the regression line. The results are the means of two independent 
experiments, each performed in duplicate. 
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Table 2.3. Comparison of IC50 values between purified lectins and different RIPs from Adenia 
genus both in reducing and non-reducing conditions. Data of lanceolin and stenodactylin are 
from Pelosi et al., 2005. 
 
 
2.1.2.2 rRNA N-glycosylase activity 
N-glycosylase activity of kirkiin was performed by RNA depurination assay of 
eukaryotic ribosomes, using a rabbit reticulocyte lysate as substrate. This activity was 
compared to that of the type 2 RIP ricin. RIPs recognize a specific and universally 
conserved region of 28S rRNA, splitting the glycosidic bond between an adenine and its 
ribose on the RNA. This site is A4324 in rat liver ribosomes and it is positioned within 
a single-stranded loop called sarcin/ricin loop (SRL). When adenine is removed, the 
treatment of the apurinic site with aniline acetate at pH 4.5 releases a 449-nucleotide 
fragment (Endo's fragment). This fragment, which is released from 3' end of 28S rRNA, 
is characteristic of the enzymatic action of RIPs (Endo et al., 1987) and can be detected 
by denaturing gel electrophoresis (5% polyacrylamide-7M urea). Kirkiin displayed the 
ability to remove the adenine on rabbit reticulocyte ribosomes, as evidenced by the 
appearance of a fragment similar to that formed by ricin. No RNA fragment was 
observed in control samples and in samples treated in absence of aniline. This result 
confirms that the ability of inhibition of protein synthesis of kirkiin is related to the N-
glycosylase activity on eukaryotic ribosomes (figure 2.6). 
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Fig. 2.6. rRNA N-glycosylase activity of kirkiin and ricin on rabbit reticulocyte 
ribosomes. Each lane contained 3 µg of RNA. The arrows indicate the RNA fragments 
released after aniline acetate treatment at pH 4.5 (+). Numbers indicate the size of the 
standards (M) in nucleotides. On the left, Sarcin Ricin Loop of the large rRNA from rat 
is represented. 
 
As the rRNA N-glycosylase activity might play a role in plant defence, for example 
against fungi, the effect of kirkiin was assayed on ribosomes from Saccharomyces 
cerevisiae, which might be homologous to ribosomes from putative plant pathogens. 
Similarly to what described above, the toxin was incubated with an S-30 lysate of yeast 
ribosomes and the apurinic rRNA was treated with aniline acetate. As shown in figure 
2.7, kirkiin and ricin displayed rRNA N-glycosylase activity on yeast ribosomes, as 
indicated by the release of the diagnostic fragment (Endo and Tsurugi, 1988) upon 
treatment with aniline acetate. The released fragments displayed sizes of 360 
nucleotides, in accordance with that expected for the SRL deglycosylation (368 
nucleotides for yeast) (Iglesias et al., 2015). Therefore, this result indicates that kirkiin 
is able to exert its action also on unicellular eukaryotes, inactivating their ribosomes. 
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Fig. 2.7. rRNA N-glycosylase activity of kirkiin and ricin on yeast ribosomes. Each lane 
contained 3 µg of RNA. The arrow indicates the Endo's fragment released after aniline acetate 
treatment at pH 4.5 (+). Numbers indicate the size of the standards (M) in nucleotides. On the 
left, Sarcin Ricin Loop of the large rRNA from S. cerevisiae is represented  
2.1.2.3 Polynucleotide:adenosine glycosylase activity 
Because of their different abilities to depurinate nucleic acids, the name of 
polynucleotide:adenosine glycosylase (PNAG) has been alternatively proposed for 
RIPs. RIPs have been shown a very variable activity on different types of nucleic acids. 
In fact, the PNAG activity of all toxic type 2 RIPs is significantly lower than type 1 
RIPs (Barbieri et al., 1997). PNAG activity of kirkiin was assayed on DNA of salmon 
sperm (ssDNA) and viral RNA of the tobacco mosaic virus (TMV) and it was compared 
with the activity of ricin. After incubation of the toxin with ssDNA, the amount of 
released adenine was determined by measuring the absorbance at 260 nm of the 
supernatant obtained by centrifugation of the samples. Both in reduced and unreduced 
conditions, no significant activity was detected on ssDNA substrate with respect to 
ricin, although the latter has a PNAG activity substantially lower than type 1 RIPs. 
According to what already observed with toxic type 2 RIPs (except for ricin) (Barbieri 
et al., 2004), kirkiin did not increase the activity on ssDNA, even after the reduction of 
the interchain disulphide bridge (figure 2.8). 
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Fig. 2.8. Polynucleotide:adenosine glycosylase activity of kirkiin and ricin on salmon sperm 
DNA (ssDNA). The amount of released adenine was determined by measuring the absorbance 
at 260 nm of the supernatant obtained by centrifugation of the samples. The results are the 
means of two independent experiments, each performed in duplicate. p<0.0001, test 
Anova/Bonferroni. 
 
Many RIPs are potent inhibitors of animal and/or plant viruses, although the mode of 
action for the antiviral activity is not still clear. The discovery of a depurinating activity 
of RIPs on viral RNA allowed hypothesizing a possible use of RIPs as antiviral agents. 
Therefore, PNAG activity of kirkiin was assayed on RNA of TMV by denaturing gel 
electrophoresis (5% polyacrylamide-7M urea) of the apurinic RNA after treatment with 
aniline acetate. A marginal depurination of RNA was observed with kirkiin with respect 
to control and it resulted slightly less than that shown by ricin (figure 2.9a). Similarly to 
what was done for the ssDNA, the amount of released adenine was determined by 
measuring the absorbance at 260 nm of the supernatant obtained by centrifugation of the 
samples. The slight adenine release induced by kirkiin on TMV RNA confirmed the 
data obtained by electrophoresis; however, the difference observed was not significant 
(figure 2.9b). 
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Fig. 2.9. Polynucleotide:adenosine glycosylase activity of kirkiin and ricin on RNA of TMV. a) 
Denaturing gel electrophoresis (5% polyacrylamide-7M urea) of the apurinic RNA after 
treatment with aniline acetate at pH 4.5 (+). Each lane contained 1 µg of RNA. b) Amount of 
released adenine determined by measuring the absorbance at 260 nm of the supernatant obtained 
by centrifugation of the samples. The results are the means of two independent experiments, 
each performed in duplicate. No significant differences were observed (confidence interval 
95%, test Anova/Bonferroni). 
2.1.2.4 Endonuclease activity on supercoiled plasmid DNA 
It was reported that some RIPs showed endonuclease activity on plasmid DNA, 
promoting the conversion of supercoiled DNA in the relaxed or linear form (Aceto et 
al., 2005). This ability can be important in order to understand the possible biological 
roles of RIPs, for example in plant defence against pathogenic micro-organisms or 
viruses.  
The endonuclease activity of kirkiin was evaluated on the pCR 2.1 plasmid and it was 
compared with ricin. The reaction consists in the incubation of the toxin with the 
plasmid and subsequent analysis of DNA on agarose gel. Both kirkiin and ricin 
promoted a slight conversion of supercoiled DNA into a relaxed form with a 
magnesium-dependent activity (figure 2.10). Therefore, kirkiin showed a weak 
endonuclease activity, much lower than that displayed by single-chain RIPs (Iglesias et 
al., 2015), and acted by cutting only one of the two helices of the plasmid DNA.  
 
 
a) b) 
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Fig 2.10. Endonuclease activity of kirkiin (Kirk) and ricin (Ric) on supercoiled plasmid DNA 
(pCR 2.1) with respect to control (C). Each lane contained 100 ng of plasmid DNA. The arrows 
indicate the supercoiled (S), the linear (L) and the relaxed (R) forms of the plasmid. Numbers 
indicate the size of the standards (M) in nucleotides and (LM) represents the linear form of the 
plasmid used as standard. 
 
 
 
Summarizing, the results obtained confirmed that kirkiin has the enzymatic 
characteristics of a type 2 RIP such as ricin, showing an evident N-glycosylase activity 
on mammalian and yeast ribosomes, but a weak activity on other nucleotide substrates. 
 
2.1.3 Isoelectric focusing 
Isoelectric focusing assay was performed to measure the isoelectric point (pI) of the 
new toxin by electrophoresis on pH gradient gel created by an ampholyne solution. 
Kirkiin showed four bands at pI values of 5.5, 5.6, 5.7 and 6. These PI values are similar 
to those found for lanceolin (range between 5.4-5.7), whereas they are slightly more 
basic than those of stenodactylin (range between 4.8-5) (Stirpe et al., 2007) and more 
acidic than those of volkensin (range between 7-7.2) (Barbieri et al., 1993) (figure 
2.11). The four bands probably indicate various isoforms of the protein, characterized 
by a different degree of glycosylation, which may determine different isoelectric points. 
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Fig. 2.11. Isoelectric focusing. Isoelectric point of kirkiin compared with the ampholyne 
gradient (St). Densitometric analysis of the bands was reported in the table on the right and 
compared with data of other Adenia RIPs (Barbieri et al., 1993 and Stirpe et al., 2007). 
2.1.4 Immunological properties 
As RIPs are highly immunogenic, an enzyme immunoassay was performed to evaluate 
the cross-reactivity between kirkiin and some sera containing antibodies against various 
double-chain and single-chain RIPs. The analysis of cross-reactivity may be of great 
interest in order to identify toxins useful for prolonged therapeutic treatment with 
immunotoxins. In fact, by varying the type of toxin it is possible to reduce the immune 
response and prolong the use of RIPs in the therapies, preserving their therapeutic 
efficacy.  
The immunological properties of kirkiin were tested with sera against different type 2 
toxins: ricin and other three RIPs of Adenia species, volkensin, stenodactylin and 
lanceolin. The new RIP highly cross-reacted with sera against Adenia toxins. This 
strong interaction is not surprising, since all these toxins have been purified from plants 
belonging to the same family and seem to have a high homology in amino acid 
sequence. Moreover, no cross-reaction was evidenced with the serum against ricin 
(figure 2.12). 
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Fig. 2.12. Enzyme-linked immunosorbent assay (ELISA) with anti-type 2 RIPs sera. The values 
of absorbance at 405 nm are expressed in function of the reciprocal of the antibody dilution. 
Values of the type 2 RIPs with the respective anti-sera are reported in (▲), while those related 
to kirkiin are represented in (■). The results are the means of at least three independent 
experiments. 
 
 
 
The new RIP was also tested with antisera against some type 1 RIPs: PAP, saporin and 
momordin. Kirkiin showed partial cross-reactivity with anti-PAP and anti-momordin 
sera, while did not react with the serum against saporin S6 (figure 2.13). No cross- 
reaction with anti-ricin and anti-saporin sera represents a good advantage, as these two 
toxins are the RIPs most used  as components of immunoconjugates (Gilabert-Oriol et 
al., 2014). This can prospect the use of a kirkiin containing-immunotoxin in prolonged 
therapeutic treatments in substitution of immunotoxins containing ricin and saporin. 
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Fig. 2.13. ELISA assay with anti-type 1 RIPs sera. The values of absorbance at 405 nm are 
expressed in function of the reciprocal of the antibody dilution. Values of the type 1 RIPs with 
the respective anti-sera are reported in (▲), while those related to kirkiin are represented in (■). 
The results are the means of at least three independent experiments. 
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2.2 Cytotoxic effects in cell cultures 
2.2.1 Inhibition of protein synthesis  
Kirkiin cytotoxicity was evaluated by its ability to inhibit protein synthesis in two 
human cell lines: HeLa (derived from uterine cervix carcinoma) and NB100 (derived 
from a neuroblastoma). Cells were treated with scalar concentrations of RIP from 10-15M 
to 10-11M for 72 hours and protein synthesis was assessed by incorporation of 3H-
leucine into the new synthesized proteins. Kirkiin resulted extremely effective on the 
tested cell lines with IC50 values extremely low, ranging from 10-14M to 10-13M. HeLa 
cells were slightly more sensitive than NB100 cells, with an IC50 value of 7.58 × 10-14M 
against 1.26 × 10-13M in NB100. For both lines, kirkiin was able to inhibit protein 
synthesis of more than 95% at the concentration of 10-12M (figure 2.14). 
 
 
 
Fig. 2.14. Inhibition of protein synthesis in Hela and NB100 cells treated with scalar 
concentrations of kirkiin. Cells (2x103/well) were incubated for 72 hours with the RIP. After 
further 4 hours of incubation in the presence of [4,5-3H]-leucine, the radioactivity incorporated 
into the new synthesized proteins was measured. Protein synthesis is represented in abscissa and 
it is expressed as percentage of control values. The results are the means of two independent 
experiments, each performed in duplicate. 
 
IC50 values of other Adenia RIPs obtained on the same cell lines are reported in table 
2.4. Kirkiin showed an IC50 on NB100 cell line comparable to the other RIPs (Stirpe et 
al., 2007), whereas the IC50 value obtained on Hela cells was comparable to that of 
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stenodactylin (1.9 × 10-14M), but much lower than those of lanceolin (1.5 × 10-12M) and 
volkensin (1.1 × 10-12M) (Battelli et al., 2010). 
 
Table 2.4. Comparison of IC50 values of kirkiin and other toxic type 2 RIPs from Adenia on 
NB100 and HeLa cells. The values of stenodactylin, lanceolin and volkensin were taken from 
Stirpe et al., 2007 and Battelli et al., 2010. 
 
 
2.2.2 Cell viability assay 
To better understand the cytotoxic mechanism induced by kirkiin, cell viability 
experiments were performed by assessing the reduction in metabolic activity, as a result 
of the treatment of the two cell lines with scalar concentrations of the RIP (from 10-15M to 
10-11M) for 72 hours. In order to verify the correlation between the two events, cell 
viability and inhibition of protein synthesis were performed in parallel. As shown in 
figure 2.15, protein synthesis and cell viability proceeded in parallel at long incubation 
time (72 hours), as commonly found with other type 2 RIPs (Wang et al., 2006). At 10-11M 
concentration, the RIP was able to reduce cell viability and to inhibit protein synthesis 
of more than 95% in NB100 cells. Regarding HeLa cells treated with kirkiin, protein 
synthesis and cell viability curves revealed a steeper trend and the RIP induced death in 
almost all of the cells (approximately 96%) at a concentration one order of magnitude 
lower (10-12M), compared to NB100 cells. 
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Fig. 2.15. Comparison of protein synthesis (♦) and cell viability (■) in Hela and NB100 cells 
treated with kirkiin for 72 hours. Both parameters are expressed as percentage of controls. The 
results are the means of three independent experiments, each performed in triplicate. 
 
The concentrations that reduce the cell viability of 50% (EC50, effective concentration 
fifty) were calculated by linear regression from the cytotoxicity curves. The EC50 values 
were 4.5 × 10-14M for NB100 and 5.3 × 10-14M for HeLa cells. As for IC50, even EC50 of 
kirkiin obtained on NB100 cells was comparable to that of stenodactylin (9.9 × 10-14M), 
but lower than that of lanceolin (6.3 × 10-13M). Even for HeLa cells was observed a 
similar behavior to that observed for the inhibition of protein synthesis, as kirkiin and 
stenodactylin resulted much more toxic than lanceolin and volkensin (table 2.5). 
 
Table 2.5. Comparison of EC50 values of kirkiin and other toxic type 2 RIPs from Adenia on 
NB100 and HeLa cells. The values of stenodactylin, lanceolin and volkensin were taken from 
Stirpe et al., 2007 and Battelli et al., 2010. NA: Not Available 
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2.2.3 Time-response experiments on NB100 cell line  
Toxins from Adenia plants are the only type 2 RIPs retrogradelly transported along the 
axon, both in peripheral nerves and in the central nervous system (Wiley and Stirpe, 
1988; Monti et al., 2007). Therefore, they are used to study the anatomy and physiology 
of the central nervous system (Wiley, 1992). For this reason, subsequent studies were 
focused on NB100 cell line of neuroblastic origin. 
In order to evaluate the minimum time required to obtain a complete loss of cell 
viability, time-course experiments were conducted on NB100 cells exposed to kirkiin at 
a concentration of 10-11M, which represented the first concentration of RIP able to 
reduce cell viability and to inhibit protein synthesis of more than 95% compared to 
controls after 72 hours. The time curve showed a significant reduction of the metabolic 
activity starting from 8 hours (about 90%), that gradually decreased over time until 
reaching a viability of about 40% at 24 hours and about 6% at 48 hours. By linear 
regression analysis, ET50 (effective time 50) of 20.4 hours was calculated, which 
represents the time necessary to reduce the cell viability of 50% (figure 2.16). 
 
 
Fig. 2.16. Time-response curve. Viability of NB100 cells (2×103 cells/well) treated with kirkiin 
(10-11M) after the indicated times. Viability was evaluated using a colorimetric assay based on 
MTS reduction. The results are the means of three independent experiments, each performed in 
triplicate, and are represented as percentage of control values obtained from cultures grown in 
the absence of RIP.**p <0.01; ****p ≤ 0.0001, Anova/ Bonferroni. 
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2.3. Assessment of apoptosis 
2.3.1. Microscopic analysis  
Many RIPs, both type 1 and type 2, are able to induce apoptosis in the intoxicated cells 
(Polito et al., 2009a). The presence of cellular morphological changes in NB100 cells 
treated with kirkiin at the concentration of 10-11M was examined using phase-contrast 
microscopy. After 16 hours of treatment, morphological characteristics of apoptosis 
were visible, which became more evident at 48 hours, such as cell shrinkage, loss of 
contact with adjacent cells, formation of cytoplasmic protrusions and apoptotic bodies 
(figure 2.17). 
 
Fig.2.17. NB100 cells morphology by phase-contrast microscopy: untreated (a, b, c) and 
treated with kirkiin at 10-11M (d, e, f) for 16, 24 and 48 hours, respectively (400× 
magnification). 
 
 
Apoptosis was monitored by fluorescence microscopy using DAPI and JC-1 staining. 
The staining of NB100 cell nuclei with DAPI showed that kirkiin intoxication induced a 
reduction of cell density and an increase of pyknotic nuclei (figure 2.18). 
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Fig. 2.18. NB100 cells morphology by fluorescence microscopy after DAPI staining: untreated 
(a) and treated with kirkiin at 10-11M for 24 hours (600× magnification). 
 
 
 
A typical feature of programmed cell death is the disruption of active mitochondria, 
which consists of changes in the membrane potential and alterations of the mitochondria 
redox state. Alterations of the mitochondrial membrane potential (∆ψm) were detected 
through fluorescence in cells exposed to kirkiin (10-11M) for 24 and 48 hours, after 
staining with JC-1, a lipophilic, cationic dye that can selectively enter the mitochondria 
and reversibly change color from green to red as the membrane potential increases. In 
healthy cells with high ∆ψm, JC-1 forms J-aggregates yielding red fluorescence. In 
apoptotic or unhealthy cells with low ∆ψm, JC-1 remains in the monomeric form with 
green fluorescence. 
Untreated cells showed a strong red fluorescence due to the characteristic J-aggregates 
in the mitochondria, indicating intact ∆ψm. In cells treated with kirkiin, JC-1 remained 
in the monomeric form, yielding green fluorescence and indicating dissipation of the 
∆ψm, which is more evident at 48 hours. These results confirm that cells undergo 
apoptosis programmed cell death after kirkiin intoxication and that mitochondria are 
involved (figure 2.19). 
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Fig. 2.19. Mitochondrial transmembrane potential in NB100 cells treated with kirkiin (10-11M) 
for 24 and 48 hours, stained with JC-1 and then analyzed with fluorescence microscopy (600× 
magnification). 
2.3.2 Cytofluorimetric analysis  
Apoptosis was also monitored by double staining with Annexin V-EGFP/Propidium 
iodide (PI) through flow cytofluorimetric analysis of NB100 cells, in order to quantify 
the percentage of apoptotic cells and evaluate the involvement of necrosis. PI-positive 
cells are in the upper left quadrant, while cells in late apoptosis and early apoptosis are 
in the upper and lower right quadrants, respectively. After 24 hours of intoxication with 
the RIP, a small percentage of treated cells were in late stage apoptosis (8.3%); this 
percentage increased over time to about 36% at 48 hours (figure 2.20). The positivity to 
Annexin V/PI in flow cytofluorimetric analysis confirmed the involvement of apoptosis 
and the absence of necrosis after kirkiin treatment of NB100 cells. 
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Fig. 2.20. Evaluation of apoptosis by Annexin V-EGFP/PI staining, followed by flow cytometry 
analysis. Representative plots of Annexin V (FITC channel)/PI (PE channel) staining of NB100 
cells untreated or treated with kirkiin (10-11 M). 
2.3.3 Caspase 3/7 activation 
To assess the involvement of caspase-dependent apoptosis, caspase 3/7 activation was 
measured in NB100 cells exposed to kirkiin 10-11M, in a time range from 4 to 48 hours. 
A strong time-dependent activation of caspase 3/7 was observed, which became 
significant with respect to control after 6 hours of treatment (143,5%) and highly 
significant after 8 hours (160%). The level of caspase activity grew exponentially over 
time, reaching a plateau after 48 hours (1093%). Instead, the reduction of viability 
became significant starting from 8 hours of treatment (91% of viability) (figure 2.21). 
The high activation level of effector caspases confirmed that the cells underwent the 
caspase-dependent apoptosis of the same magnitude compared with other toxic type 2 
RIPs and at very low doses (10-11M) (Polito et al., 2016a). 
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Fig. 2.21. Caspase 3/7 activation (columns) in NB100 cells (2×103cells/well) treated with 
kirkiin (10-11M), compared with cell viability (■). Caspase activity was expressed as percentage 
of control values obtained from cultures grown in the absence of RIP. The results are the means 
of three independent experiments, each performed in triplicate. p<0.01, ****p<0.0001, Anova/ 
Bonferroni test. 
 
Summarizing, kirkiin-treated cells exhibited the morphological features characteristic 
of apoptosis and stimulated the apoptotic pathway as demonstrated by the strong 
activation of the effector caspase 3/7 and the positivity to Annexin V/PI in flow 
cytofluorimetric analysis. 
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2.4 Kirkiin amino acid sequence  
2.4.1 Isolation and cloning of the kirkiin gene 
2.4.1.1 Selection of the oligonucleotides for PCR amplification 
The nucleotide sequence of kirkiin was partially determined from DNA extracted from 
the caudex of A. kirkii, by PCR with gene-specific primers designed on the basis of the 
sequences available for other Adenia RIPs (stenodactylin, modeccin, lanceolin A1, 
lanceolin A2 and volkensin), as described in section 4.2.11. As a result of the high 
sequence homology among RIPs derived from plants of Adenia and on the basis of the 
information available in GenBank on volkensin amino acid sequence (CAD61022), five 
oligonucleotides were designed for PCR amplification of the kirkiin gene: three primers 
for kirkiin A-chain amplification, two based on the N-terminal end (A1 and the 
degenerated A2) and one on the B-chain N-terminal (B1 reverse); and two primers for 
kirkiin B-chain amplification (B1 and B5 reverse) in the N-terminal and C-terminal 
ends, respectively (figure 2.22). The sequences of the primers are reported in section 
4.2.11. The primer A1, designed in proximity of N-terminal end of the A-chain did not 
produce amplification, did not allowing the determination of the N-terminal end of the 
protein (about 10 amino acids on the basis of Adenia sequences alignement). As a 
consequence, kirkiin amino acid sequence was determined by using the A2 primer. 
 
 
Fig. 2.22. Schematic representation of kirkiin gene precursor. Black arrows represent the 
primers designed for PCR amplification of the kirkiin gene. The sequences of the primers are 
reported in section 4.2.11. (A) is the sequence encoding A-chain; (B) is the sequence encoding 
B-chain; (N) and (C) are the N-terminal and C-terminal ends of the kirkiin gene, respectively. 
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2.4.1.2 Molecular cloning and sequencing of genomic DNA fragments encoding 
kirkiin 
Total DNA was extracted from the caudex of A. kirkii through DNeasy Minikit (Qiagen) 
according to the manufacturer’s instruction. From approximately 100 mg of frozen 
tissue, 1.2 µg of total DNA were obtained. Genomic DNA was used as template for 
PCR amplification in order to determine the amino acid sequence of kirkiin (section 
4.2.12). Two pairs of primers allowed to amplify two genomic DNA fragments 
corresponding to: the A-chain with part of the B-chain (A2 and B1R primers) and the 
entire sequence of kirkiin (A2 and B5R primers). The primers designed for B-chain 
generated an artifact of amplification (B1 and B5R primers). The amplified fragments 
were analyzed by agarose gel electrophoresis, showing the expected size of about 0.8 kb 
for the A-chain with part of the B-chain (figure 2.23 A, lane 1) and about 1.6 kb for the 
entire sequence (figure 2.23 B, lane 1). 
 
 
 
 
Fig. 2.23. Amplification of kirkiin A-chain with part of the B-chain (A, lane 1), and the entire 
sequence (B, lane 1). Mw: λ Hind III/EcoRI double digest DNA marker. The red squares 
indicate the amplification products. 
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The two purified amplicons were cloned into the vector pCR®II used for the 
transformation of highly competent cells InVαF'. The antibiotic-resistance conferred by 
the plasmid vector, allowed the growth of transformed bacterial cells only. The 
recombinant white colonies (lacZ-negative; see section 4.2.13) were analyzed by PCR, 
using the universal primers "M13" and "M13 reverse". The population of transformants 
positive for the presence of the fragments corresponding to the A-chain with part of the 
B-chain and the entire protein was 8/8 and 4/30, respectively.  
The transformed white colonies were picked up for plasmid purification and restriction 
analysis with EcoR1 enzyme. The agarose gel analysis reported in figure 2.24 showed 
that plasmids corresponding to the A-chain with part of the B-chain (gel A), contained 
fragments of the expected size after plasmid digestion (about 0.8 kb), whereas the 
plasmids corresponding to the entire sequence (gel B) revealed the presence of two 
bands of about 0.9 kb and 0.7 kb after digestion. This result was probably due to the 
presence of a restriction point for EcoR1 inside the kirkiin sequence. 
 
 
 
Fig. 2.24. Restriction analysis of the purified plasmids digested with EcoR1 enzyme (+) and 
non-digested (-). The agarose gel A shows the digestion of two plasmids containing the A-chain 
with part of the B-chain (lanes 1 and 2); the agarose gel B shows the digestion of two plasmids 
containing the entire sequence (lanes 1 and 2). Mw: λ Hind III/EcoRI double digest DNA 
marker.  
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To exclude that the amplification had generated a non specific band, a further PCR 
amplification of the purified plasmids corresponding to the entire sequence was 
performed with the specific primers (A2 and B5R). A fragment of the expected size 
(about 1.6 kb) was obtained (figure 2.25). 
 
Fig. 2.25. PCR amplification of the purified plasmids corresponding to the entire sequence with 
the specific primers (A2 and B5R). Both lanes showed the amplification of a fragment of about 
1.6 kb. Mw: λ Hind III/EcoRI double digest DNA marker.  
 
The purified plasmids were sequenced by CENIT Support system of Villamayor 
(Salamanca, Spain). The information obtained on the sequence were analyzed using the 
algorithms available on http://expasy.org. The genomic DNA sequences obtained for the 
A-chain with a part of the B-chain and for the entire sequence (were aligned and 
reported in figure 2.28.  
2.4.1.3 Molecular cloning and sequencing of a cDNA encoding kirkiin A-chain 
Total RNA was extracted from the caudex of A. kirkii through RNeasy Minikit (Qiagen) 
according to the manufacturer’s instruction. From approximately 100 mg of tissue, 
about 2.7 µg of total RNA were obtained. Reverse transcription was performed with 1 
µg of total RNA using the primer ATP-J1, as explained in section 4.2.10. The obtained 
cDNA was used as template for PCR amplification with the same primers used for the 
sequencing of the genomic DNA (see section 4.2.12). A pair of primers allowed to 
amplify a cDNA fragment corresponding to the A-chain with part of the B-chain (A2 
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and B1R). As seen for genomic DNA, the primers designed for B-chain generated an 
artifact of amplification. The amplified fragment was analyzed by agarose gel 
electrophoresis, showing the expected size of about 0.8 kb (figure 2.26).  
 
 
 
Fig. 2.26. Amplification of kirkiin cDNA corresponding to A-chain with part of the B-chain 
(lane 2). Mw: λ Hind III/EcoRI double digest DNA marker. The red square indicates the 
amplification product. 
 
As before, after ligation of the fragments into pCR®II vector and transformation of 
E.coli InVαF' cells, plasmids were purified and analyzed by restriction digest with 
EcoR1 enzyme. The agarose analysis was reported in figure 2.27. The purified plasmids 
were sequenced by CENIT Support system of Villamayor (Salamanca, Spain).  
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Fig. 2.27. Restriction analysis of the purified plasmid digested with EcoR1 enzyme (+) and non-
digested (-). The agarose gel shows the digestion of a plasmid containing the A-chain with part 
of the B-chain. Mw: λ Hind III/EcoRI double digest DNA marker.  
 
Below, the cDNA sequence encoding kirkiin A-chain with part of the B-chain was 
represented in alignment with the genomic DNA sequences obtained for the A-chain 
with part of the B-chain and for the entire sequence (of which only positions from 1 to 
794 are represented) (figure 2.28). The sequences differ in two nucleotides (positions 
351 and 504, represented in box in the figure); however, they are included in codons 
which encode the same amino acids (CAC/CAT encoding His and GTC/GTT encoding 
Val in positions 351 and 504, respectively). These differences can be due to the 
presence of gene isoforms or simply to errors introduced by Taq Polymerase during the 
amplification. 
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Fig. 2.28. Alignment between the cDNA sequence encoding kirkiin A-chain (A cDNA) and 
DNA sequences encoding the A-chain with part of the B-chain (A genomic) and the entire 
sequence (AB genomic), of which only positions from 1 to 794 are represented. Identical 
residues (*). The sequences differ in two nucleotides (positions 351 and 504, represented in box 
in the figure).  
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2.4.2. Sequence analysis 
 
The full-length kirkiin gene, missing the N-terminal portion, showed an ORF of 1539 
bp, encoding a protein of 513 amino acids. The gene contains 721 bp encoding the A-
chain (240 amino acids with a theoretical Mw of 28324.21 Da) and 774 bp encoding the 
B-chain (258 amino acids with a theoretical Mw of 28506.13 Da), separated by a 
sequence linker of 45 bp (15 amino acids between amino acids 241 and 255). The C-
terminal end of the A-chain and the linker sequence was estimated on the basis of the 
homology with the volkensin gene (figure 2.29). The restriction sites analysis through 
the program Webcutter 2.0 confirmed the presence of a restriction point for EcoR1 in 
kirkiin B-chain (position 844, g/aattc). 
In order to identify the structurally conserved regions, multiple sequence alignments 
were performed between kirkiin and several toxic and non-toxic type 2 RIPs, using the 
program Clustal Omega. Kirkiin amino acid sequence shows a high percentage of 
identity with RIPs purified from plants of the same genus (96% with stenodactylin and 
87% with volkensin), whereas a lower identity ranging from 36% to 41% is evidenced 
with other type 2 RIPs, amongst which the highest identity is shown with ricin (41.4%). 
A higher degree of identity can be observed among B-chains (ranging from 42% to 
48%, except for Adenia RIPs) with respect to A-chains (table 2.6). This data are in 
agreement with those previous reported in the literature for other type 2 RIPs (Barbieri 
et al., 1993). The high sequence homology supported the hypothesis that RIP B-chain is 
a product of a gene duplication event (Di Maro et al., 2014). 
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gccacggtagagaggtacactcagtttataatgctcttaaggaacgaactggcgggtgat 60 
 A  T  V  E  R  Y  T  Q  F  I  M  L  L  R  N  E  L  A  G  D  20 
gtttctccacagggaatacgcaggctgaggaatccggctgatattcagccttcacagcgt 120 
 V  S  P  Q  G  I  R  R  L  R  N  P  A  D  I  Q  P  S  Q  R  40 
tttattcttatacaactcaacggcttcgtaggctccgtcaccttgataatggacgtcagc 180 
 F  I  L  I  Q  L  N  G  F  V  G  S  V  T  L  I  M  D  V  S  60 
aatgcgtatctattgggttatgagagccgcaactttgtgtatcacttcaacgatgtctct 240 
 N  A  Y  L  L  G  Y  E  S  R  N  F  V  Y  H  F  N  D  V  S  80 
acctcttcgatcgccgatgttttcccagacgtacaacgtcaacagttgccatttgaaggc 300 
 T  S  S  I  A  D  V  F  P  D  V  Q  R  Q  Q  L  P  F  E  G  100 
ggctatcccagcatgcgacactatgcgccggagagagatcaaattgaccacggattcatc 360 
 G  Y  P  S  M  R  H  Y  A  P  E  R  D  Q  I  D  H  G  F  I  120 
gaactggcatacgctgttgatacgctctactatagtagtcaaggctacgaacagatcgcg 420 
 E  L  A  Y  A  V  D  T  L  Y  Y  S  S  Q  G  Y  E  Q  I  A  140 
cgttcactcgtgctctgcgccgggatggttgcagaagccgcccggttccgctacatcgag 480 
 R  S  L  V  L  C  A  G  M  V  A  E  A  A  R  F  R  Y  I  E  160 
gggctggtgcgtcaaagcattgtcgggccaggagactacggaactttcagaccggatgcg 540 
 G  L  V  R  Q  S  I  V  G  P  G  D  Y  G  T  F  R  P  D  A  180 
ttgatgtactcagtcgtgacagcgtggcagactctttcagaaagaatccagggatccttc 600 
 L  M  Y  S  V  V  T  A  W  Q  T  L  S  E  R  I  Q  G  S  F  200 
gacggagctttccagccagttcagctggggtatgccagcgatcccttttattgggacaac 660 
 D  G  A  F  Q  P  V  Q  L  G  Y  A  S  D  P  F  Y  W  D  N  220 
gtcgcacaggccatcaccaggctgtcactcatgctattcgcctgcgctaaacctccaagg 720 
 V  A  Q  A  I  T  R  L  S  L  M  L  F  A  C  A  K  P  P  R  240 
caatccgattcccccatggtgataaggtcctttgtggataggaacgatcctgtctgccct 780 
 Q  S  D  S  P  M  V  I  R  S  F  V  D  R  N  D  P  V  C  P  260 
tccggggagacgactgcgtacatcgtggggcgggacgggcgctgtgtggacgtgaaggat 840 
 S  G  E  T  T  A  Y  I  V  G  R  D  G  R  C  V  D  V  K  D  280 
gaggaattcttcgacggcaataaagtacagatgtggccgtgcaagtccagccagaatgca 900 
 E  E  F  F  D  G  N  K  V  Q  M  W  P  C  K  S  S  Q  N  A  300 
aaccagctgtggactataaagagagacggcactattcggtgcaagggaaagtgcttgact 960 
 N  Q  L  W  T  I  K  R  D  G  T  I  R  C  K  G  K  C  L  T  320 
gtgaggagcccgcaactgtacgctatgatctggaactgcaccactttttatgctcctgcc 1020 
 V  R  S  P  Q  L  Y  A  M  I  W  N  C  T  T  F  Y  A  P  A  340 
accaagtgggaagtgtgggacaacgggaccatcatcaaccccgcctccgggagggtgttg 1080 
 T  K  W  E  V  W  D  N  G  T  I  I  N  P  A  S  G  R  V  L  360 
accgcgtccactggggacgcgggcgtcgtcctcagcctggagcacaacgagaacgccgct 1140 
 T  A  S  T  G  D  A  G  V  V  L  S  L  E  H  N  E  N  A  A  380 
agccaggcgtggagagtgaccaatgtgacagcacctacggtgacaaccattgtgggatat 1200 
 S  Q  A  W  R  V  T  N  V  T  A  P  T  V  T  T  I  V  G  Y  400 
gatgatctctgcctggaaaccaacgacagcaatgtatggttggccaactgcgtgaaaggc 1260 
 D  D  L  C  L  E  T  N  D  S  N  V  W  L  A  N  C  V  K  G  420 
aagacgcaacagagatgggcgcagtatgcggatggcaccatacgctcccagtccagcctc 1320 
 K  T  Q  Q  R  W  A  Q  Y  A  D  G  T  I  R  S  Q  S  S  L  440 
agcaaatgcctcacctgcagtggcgactgcgtcaagctggcaaagatcgtcaacacggac 1380 
 S  K  C  L  T  C  S  G  D  C  V  K  L  A  K  I  V  N  T  D  460 
tgtgctggatccgccttgagccgttggtacttcaacacctttggcggcatcgtgaatctg 1440 
 C  A  G  S  A  L  S  R  W  Y  F  N  T  F  G  G  I  V  N  L  480 
ttgaccgacatggtgatggacgtgaaagagtccaatccgagtctcaacgaaataattgcc 1500 
 L  T  D  M  V  M  D  V  K  E  S  N  P  S  L  N  E  I  I  A  500 
cacccgtggcatggaaactccaaccagcaatggttccta 1539 
 H  P  W  H  G  N  S  N  Q  Q  W  F  L   513 
 
 
Fig. 2.29. Full length sequence and derived amino acid sequence of the kirkiin gene. The A 
chain is represented in blue, the B chain in red and the sequence of the linker peptide in green. 
Black arrows indicate the position of the primers used for PCR amplification. 
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Table 2.6. Identity of A-chains, B-chains and complete sequences among kirkiin and nine type 
2 RIPs. 
 
 
Given the availability of kirkiin amino acid sequence, it was possible to predict the 
three-dimensional structure with a computational model. The program I-TASSER 
(Treading Assembly Refinement) was used, which builds the 3D structure of the protein 
of interest by implementing several threading programs and comparing the predicted 
models with those present in databank. The missing N-terminal end of kirkiin was 
replaced with that of volkensin, in order to avoid introducing errors during the folding 
of the protein. 
On the basis of the sequence homology (41.4%) and of the crystallographic analysis 
available in databank, ricin (PDB entry code 2aai) was used as a reference model in 
order to obtain useful information on amino acids directly or indirectly involved in the 
toxic activity and to identify any structural differences that may affect the function of 
the protein. The alignment with ricin was imported in “Discovery Studio 3.5 suite” 
program for manual processing, introducing appropriate gaps in the sequence and 
maintaining the alignment of the conserved regions (figure 2.30). This analysis 
highlighted that the overall folding of ricin is conserved in kirkiin, apart from few 
discrepancies due to some deletions and insertions in loop regions (figure 2.31). The A-
chain consists of three domains: the first domain includes the N-terminal end and is 
composed of six β-sheets and two α-helices; the second domain is the most conserved 
among the A-chains of type 2 RIPs and is formed by five α-helices; the third domain 
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consists of two α-helices, two antiparallel β-sheets and an unstructured coil region in the 
C-terminal. Similarly to other type 2 RIPs, kirkiin B-chain is made of two similar 
globular domains, exclusively formed by β-sheets in a trefoil structure (three β-sheets, 
one-loop and one β-sheet). Each domain consists of three main sub-domains (1α, 1β and 
1γ for the domain 1; 2α, 2β and 2γ for the domain 2), which are homologous to the 
corresponding sub-domains of ricin B-chain (figure 2.32). Only two of these sub-
domains, 1α and 2γ, bind galactose. Two further subdomains are represented, 1ʎ and 2ʎ, 
responsible for the bind to the A-chain and for the interconnection between the two B-
chain domains, respectively (figure 2.30). 
 
 
 
 
 
Fig. 2.30. Kirkiin 3D model predicted by I-TASSER protein structure prediction program and 
crystallographic analysis of ricin (PDB entry code 2aai). 
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Fig. 2.31. Ricin and kirkiin structure folding by alignment imported in Discovery Studio 
program. RMSD 1.75 Å. 
 
 
 
Fig. 2.32. Alignment of the amino acid sequence stretches of the homologous subdomains of 
ricin B-chain (1α, 2α, 1β, 2β, 1γ, 2γ) with the corresponding stretches of kirkiin B-chain (1α’, 
2α’, 1β’, 2β’, 1γ’, 2γ’). Identical residues are boxed and conserved hydrophobic residues are 
indicated by asterisks (*). The cysteine residues participating in forming disulfide bridges in the 
α and β subdomains are represented in yellow. The position of Cys206 in the subdomain 2β’ of 
kirkiin is shifted by two positions when α and β subdomains are aligned. The amino acids 
involved in the carbohydrate-binding sites are highlighted in green. 
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As previously reported in table 2.6, kirkiin A-chain showed a sequence homology with 
volkensin and ricin A-chains of 84.4% and 35.1%, respectively. It includes two cysteine 
residues, Cys157 and Cys246, the latter located at the C-terminal (figure 2.33). Kirkiin 
B-chain, instead, showed a higher sequence homology with volkensin and ricin B-
chains, with identity values of 89.2% and 48.4%, respectively. The B-chain has twelve 
cysteine residues, three more than those present in ricin. It is known for other type 2 
RIPs that the C-terminal cysteine of the A-chain forms an interchain disulfide bridge 
with the cysteine at the N-terminal of the B-chain and that the two domains of the B 
chain are each organized around two disulfide bridges. On the basis of the sequence 
alignments with other type 2 RIPs and of the three-dimensional structure, it seems that 
this scheme is also present in kirkiin. As regards the three more cysteines sited on the B-
chain, on the basis of the 3D model, the Cys59 seems to be isolated in the domain 1, 
while the other two (Cys191 and Cys195) are located in a loop in the domain 2, close 
enough to form a disulfide bridge. Therefore, it might be interesting to investigate the 
role of these cysteine residues of kirkiin B-chain and if their reduction can affect the 
biological property of the molecule. 
Two possible glycosylation sites were detected by the program NetNGlyc1.0 in the B-
chain at the position Asn93-Gly94-Thr95 and Asn133-Val134-Thr135. The presence of 
carbohydrates could explain the difference in the molecular weight of the B chain 
calculated on the basis of the amino acid sequence (28.5 kDa) and that observed by 
electrophoretic mobility (35 kDa) (figure 2.33). 
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Fig. 2.33. Protein sequence alignment of kirkiin with ricin (acc.no P02879) and volkensin 
(acc.no CAD61022). The missing N-terminal end of kirkiin was replaced with that of volkensin 
(represented in red). Identical residues (*), conserved substitutions (:) and semi-conserved 
substitutions (.) are reported. Cysteine residues are highlighted in yellow. The position of 
Cys206 in ricin B-chain is shifted by one position after the alignment. The amino acid residues 
formed the active site are highlighted in gray, whereas the amino acids involved in the 
carbohydrate-binding sites are highlighted in green. The positions of the intramolecular and 
intermolecular disulfide bonds of ricin are indicated by solid lines. The possible glycosylation 
sites are highlighted in light blue. Dashes denote gaps introduced to obtain maximal homology. 
 
 
A-chain 
B-chain 
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A study on amino acids conservation among various type 2 RIPs was carried out for 
both A- and B-chains. The analysis was performed using 41 amino acid sequences of A-
chains of type 2 RIPs and 46 amino acid sequences of B-chains and lectins. The 
sequence alignments were performed using the Mega6 program with the default 
parameters manually modified aligning a number of amino acids characteristic of the 
sequences, such as those of the active site for the A-chains and the cysteines for the B-
chains. The aligned sequences were graphically represented by sequence logos created 
with WebLogo 3 (figure 2.34). On the basis of the structure obtained for kirkiin, the 
conserved amino acids for each chain were represented with “Discovery Studio3.5 
suite” program (figure 2.35 for A-chain and 2.36 for B-chain). In this representation, it 
was highlighted not only the conserved amino acids of the active site and of the 
galactose binding sites, but also the most conserved outside of these sites.  
As regards the A-chain, most of the highly conserved amino acids among type 2 RIPs 
are also conserved in kirkiin. Alignment of amino acid sequences shows that the amino 
acids responsible for the enzymatic mechanism of the active site are conserved in all the 
A chains of type 2 RIPs and are also present in kirkiin: Tyr74, Tyr113 and Trp200 
(Tyr100, Tyr144 and Trp241 in the sequence logo) are the amino acids responsible for 
the substrate binding to the active site, whereas Glu163 and Arg166 (Glu202 and 
Arg205 in the sequence logo) are the amino acids responsible for the N-glycosylase 
activity of the protein. In figure 2.37, the amino acids of the active site of kirkiin and 
ricin A-chains are represented in detail. These residues are located in equivalent 
positions in the three-dimensional structure of ricin and kirkiin, creating a kind of 
pocket among the three domains of the A chain, although the orientation of some of 
them in kirkiin can vary with respect to ricin. Another highly conserved amino acid 
located in the active site, Phe167 (206 in the sequence logo), is also present in kirkiin; 
its function is still unclear, but seems to be involved in stabilizing the conformation of 
the side chain of Arg166 (Di Maro et al., 2014). Other amino acids in the active site that 
can interact with the adenine are not conserved. It is known that RIPs may use different 
ways to bind the substrate. Some residues located near the active site of ricin (Asn78, 
Arg134, Gln173, Ala178, Glu208 and Asn209) are probably involved in the 
stabilization of the active site and almost all are conserved among the A-chains of type 
2 RIPs, with the exception of kirkiin. In the A chain of the latter, Asn78, Arg134 and 
Ala178 of ricin are conserved (Asn72, Arg123 and Ala164 in kirkiin, respectively), 
while Gln173, Glu208 and Asn209 are replaced in kirkiin by Gly159, Val197 and 
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Thr198, respectively. These substitutions are also present in stenodactylin and volkensin 
A-chains (Chambery et al., 2004). In addition, Ser204 (245 in the sequence logo) 
located close to the active site and evolutionarily conserved among RIPs with the 
function of stabilizing the conformation of the side chain of Trp200 (Chambery et al., 
2007), is also conserved in kirkiin.  
In figures 2.38 and 2.39, 1α and 2γ galactose-binding sites of kirkiin and ricin B-chains 
are represented. The amino acid residues involved in the binding are located in 
equivalent positions in the three-dimensional structure of both proteins, although the 
orientation of some of them in kirkiin can vary with respect to ricin. All the amino acids 
involved in 1α binding domain of ricin B-chain are conserved in kirkiin (Asp22, Gln35, 
Trp37, Asn46 and Gln47). All amino acids residues forming the 2γ sugar-binding site of 
ricin are conserved in the B-chain of kirkiin (Asp232, Ile244, Asn253 and Gln254), with 
the exception of the residue Tyr248 that is replaced by His246 in kirkiin. The same 
substitution was observed in volkensin (Chambery et al.,2004), in R. communis 
agglutinin (Roberts et al., 1985) and in PMRIPm of P. multiflorum (Van Damme et al., 
2000). Mutagenesis site-specific studies on ricin B-chain showed that the substitution of 
Tyr248 with His remarkably reduced the binding activity to the galactose (Lehar et al., 
1994). In fact, the introduction of a positive charge in the 2γ binding site prevents the 
hydrophobic interaction between the pyranose ring of galactose and the aromatic ring of 
tyrosine, reducing the function of the lectin domain. Moreover, in ebulin l the 
substitution of Tyr248 of ricin with the aromatic residue Phe is responsible of its 
reduced toxicity. The assumption that this substitution in 2γ domain would affect the 
binding activity of the protein, does not correlate with the results obtained for kirkiin. 
On the contrary, kirkiin is highly cytotoxic, although this change in 2γ domain.  
The majority of highly conserved amino acids among RIP B-chains are also conserved 
in kirkiin, with the exception of Cys59, Arg103, Gln173 and Ser212. Only three amino 
acids localized in 1α galactose binding site of kirkiin are highly conserved, Asp22 (27) 
Asn46 (55) and Gln 47 (56); while in 2γ domain all the amino acids are preserved 
except His246. As reported in the literature, other highly conserved amino acids, not 
involved in the sugar-biding, seem to be important in maintaining the symmetry of the 
domains (Di Maro et al., 2014). 
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Fig. 2.34. Amino acids conservation among A-chains (up) and B-chains (down) of type 2 RIPs. 
The analysis was performed using 41 amino acid sequences of A-chains of type 2 RIPs and 46 
amino acid sequences of B-chains and lectins, aligned with the Mega6 program. The height of the 
letters is proportional to the frequency of that amino acid in that position with respect to all the 
amino acids, while the width corresponds to the frequency of that amino acid including the gaps of 
the sequences . 40/53 highly conserved amino acids are conserved in kirkiin A-chain; 64/69 highly 
conserved amino acids are conserved in kirkiin B-chain.  
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Fig. 2.35. 3D representation of kirkiin A-chain, in which the amino acids conserved among type 2 
RIPs are represented. Adenin is represented in green. The amino acids conserved inside the active 
site are represented in dark red (>90%) and in light red (>80%); the amino acids conserved outside 
the active site are represented in dark blue (>90%) and in light blue (>80%); non-conserved amino 
acids are represented in grey.
90° 
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Fig. 2.36. 3D representation of kirkiin B-chain in which the amino acids conserved among type 2 
RIPs are represented. The sugar is represented in green. The amino acids conserved inside the 
sugar-binding site are represented in dark red (>90%) and in light red (>80%); the amino acids 
conserved outside the sugar-binding site are represented in dark blue (>90%) and in light blue 
(>80%); non-conserved amino acids are represented in grey. 
90° 
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Fig. 2.37. 3D representation of the amino acids of the active site of kirkiin and ricin A-chains. 
Adenin is represented in green. Docking was predicted with COACH program. 
 
 
 
 
 
Fig. 2.38. 3D representation of the amino acids of 1α domain of kirkiin and ricin B-chains. 
Lactose is represented in green. Docking was predicted with COACH program. 
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Fig. 2.39 3D representation of the amino acids of 1α domain of kirkiin and ricin B-chains. 
Galactose is represented in green. Docking was predicted with PATCHDOCK program. 
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CONCLUSION 
This study demonstrates that A. kirkii contains a high amount of two proteins that have 
the characteristics of galactose-specific lectins and agglutinate erythrocytes. In 
particular, one of these, called kirkiin, shows biochemical, enzymatic and cytotoxic 
characteristics of type 2 RIPs. Kirkiin shows N-glycosylase activity on mammalian and 
yeast ribosomes, but little or no activity on other nucleotide substrates (viral RNA, 
ssDNA). This toxin is able to completely inhibit protein synthesis both in a cell-free 
system and in cells and to induce cell death by apoptosis at very low doses in the tested 
cell lines. 
The toxin is immunologically similar to other Adenia toxins, which is not surprising, in 
that they all came from plants belonging to the same Passifloraceae family and have 
many similarities in their amino acid sequences. Kirkiin partially cross-reacts with sera 
against type 1 RIPs momordin and PAP, while does not react with sera against ricin and 
saporin S6. This results represent a remarkable advantage in prospecting the use of an 
immunotoxin containing kirkiin in prolonged therapeutic treatments in substitution to 
immunotoxins containing ricin and saporin, which are two of the most used RIPs as 
toxic components of immunoconjugates. 
The amino acid sequence analysis showed that kirkiin possesses all the characteristics of 
a protein with N-glycosylase enzymatic activity. Despite differences in the amino acid 
sequence with respect to other RIPs, the results of the modelling studies indicated that 
the three-dimensional structure of kirkiin preserves the overall folding of type 2 RIPs.  
The hypothesis that the substitution of His246 in kirkiin 2γ domain can affect the 
binding, does not correlate with the results obtained by cytotoxicity. Another interesting 
aspect is that, despite the high degree of conservation of amino acid residues of both A- 
and B-chains, kirkiin shows a difference in terms of toxicity compared with other type 2 
RIPs. Further studies on the conservation of polar and hydrophobic interactions both on 
the interface between the chains and on the domains near the active site will be useful, 
in order to fully understand the correlation between structure and function of the 
molecule and in general of all RIPs. Any differences could clarify the interaction with 
various nucleotide substrates and the different biological behavior of the toxin, not due 
to differences in the active site.  
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In conclusion, the high cytotoxicity of kirkiin and other toxins derived from plants of 
the genus Adenia represents an important opportunity for the present and future 
development of new drugs, both native, for limited local treatments, and conjugated to 
carrier molecules selective for tumor cells, for local or systemic treatments. Moreover, 
the assessment of the ability of these toxins to be transported in a retrograde manner in 
the central nervous system may have very interesting applications in neuroanatomy, 
neurophysiology and therapy. 
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AIM OF THE PROJECT 
Sambucus RIPs, both type 1 and type 2, are able to strongly inhibit protein synthesis in 
a cell-free system consisting of a rabbit reticulocytes lisate, with IC50 in nM range 
(Girbes et al., 1993a, b). Despite this, type 2 RIPs from Sambucus showed a low 
cytotoxicity, comparable to that of type 1 RIPs, even though they are endowed with 
lectin activity. Thanks to their high enzymatic activity and low non-specific toxicity, the 
two non- toxic type 2 RIPs ebulin l, extracted from the leaves of S. ebulus, and nigrin b, 
extracted from the bark of S. nigra (figure 1), have been used to construct 
immunotoxins directed towards the transferrin receptor, highly expressed in some cell 
lines and in many human tumors (Citores et al., 2002), and immunotoxins specific for 
the endothelial receptor CD105 (endoglin), strongly expressed during neo-angiogenesis 
and in vessels of tumor tissues (Benítez et al., 2005; Muñoz et al., 2007). These 
immunotoxins showed high cytotoxicity with IC50 values in the picomolar range. The 
use of ebulin l and nigrin b as component of immunotoxins could present some 
advantages with respect to toxic type 2 RIPs: less probability to develop VLS; less 
systemic toxic effects when toxins are released outside of the target cells, after breakage 
of the bond with the antibody; and more safety for the operator during the purification 
processes (Ferreras et al., 2011). 
The understanding of cell death pathways implicated in RIP intoxication represents an 
important aspect both in preclinical and clinical studies, as in cancer therapy it is 
important to choose a toxin that does not induce necrosis, in order to reduce or avoid 
side effects. 
 
 
Fig. 1. Leaves of S. ebulus(on the left) and bark of S. nigra (on the right). 
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Despite the potential and the therapeutic value of ebulin l and nigrin b have been well 
described, the pathogenic mechanism of their toxicity remains unsolved.  
The study carried out in this thesis was focused on understanding the pathogenesis of 
the cellular intoxication induced by the non-toxic type 2 RIPs from Sambucus in a 
neuroblastoma-derived cell line, which is particularly sensitive to RIPs both single-
chains and double-chains (Barbieri et al., 1993). The obtained results were compared 
with those of the toxic type 2 RIPs ricin and stenodactylin and the type 1 RIP saporin. 
Knowledge about the cell death mechanisms implicated might allow a better 
pharmacological use of these toxins, with an increase in their therapeutic efficacy 
against target cells. 
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RESULTS AND DISCUSSION 
In a preliminary study, ebulin l and nigrin b showed a strong ability to inhibit protein 
synthesis in vitro in a cell-free system consisting of a lysate of rabbit reticulocytes. The 
IC50 values resulted 8.7 ng/ml and 5.4 ng/ml for ebulin l and nigrin b, respectively. 
These data were comparable to those reported in the literature for other type 1 and type 
2 RIPs (Ferreras et al., 2011). In table 3.1, IC50 values of ebulin l and nigrin b were 
compared with those of ricin and stenodactylin, and the single-chain RIP saporin. The 
IC50 values of the two RIPs from Sambucus are of the same order of magnitude of both 
ricin and saporin. The high IC50 of stenodactylin (already described in the literature by 
Stirpe et al., 2007) has been justified with the difficulty to reduce the interchain 
disulphide bridge of the molecule without inactivating the A-chain. 
 
Table 3.1: Effect of type 1 and type 2 RIPs on protein synthesis in a cell-free system consisting 
of a lysate of rabbit reticulocytes.  
* probable incomplete reduction of the RIP 
 
Despite of the high translational inhibition activity in the cell-free system, ebulin l and 
nigrin b showed a low cytotoxicity on NB100 cells, with EC50 values quite similar for 
both toxins from Sambucus (10-8M), but 5-6 log higher than toxic type 2 RIPs and 3 log 
higher than saporin (table 3.2). These results reflect experimental evidence already 
described in the literature in other cellular models (Ferreras et al., 2011). The low 
toxicity of Sambucus RIPs could be traced back to a low binding affinity for the 
membrane receptors. Moreover, their lower toxicity compared to that of type 1 RIPs,  
probably suggests an inefficient translocation across the plasma membrane, an 
ineffective reduction of the disulphide bond between A- and B-chains, or an 
unfavorable intracellular routing, which would impact on their toxic effect (Battelli et 
al., 1997; Rojo et al., 1997). 
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Table 3.2: Comparison of EC50 of type 2 RIPs (toxic and non-toxic) and the type 1 RIP saporin 
in NB100 cells, after 48 hours of incubation with RIPs. 
3.1. Cell viability assay 
As non-toxic type 2 RIPs showed a low totoxicity to NB100 cell line, subsequent 
studies were conducted using the two RIPs from Sambucus at a concentration of 10-7M, 
that was 10 times higher than the EC50 value, in order to obtain a more marked 
cytotoxic effect and to better understand the pathways implicated in cell death. Time-
course experiments were conducted in a range between 4 and 96 hours and the viability 
was assayed using a colorimetric method based on MTS reduction. 
The viability curves corresponding to the two toxins showed a similar trend. Ebulin l 
and nigrin b significantly reduced cell viability after 8 hours (p<0.01), which gradually 
decline until reaching a viability of less than 60% at 24 hours and about 10% at 72 
hours for both toxins. The cell viability is completely reduced to 0 after 96 hours (figure 
3.1). The time necessary to reduce the viability of 50% (ET50) was calculated by linear 
regression interpolation. Ebulin l showed an ET50 after 24.4 hours with an r2 of 0.978, 
while in nigrin b it was obtained after 26.3 hours with an r2 of 0.969. 
These results suggested that ebulin l and nigrin b were both able to completely eliminate 
NB100 cells; however, they need more time than other RIPs to fully carry out their 
cytotoxic effect. 
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Fig. 3.1. Time-response curve. Viability of NB100 cells (2×103 cells/well) treated with ebulin l (10-
7M) and nigrin b (10-7M) after the indicating times. Viability was evaluated using a colorimetric 
assay based on MTS reduction. The results are the means of three independent experiments, 
each performed in triplicate, and are represented as percentage of control values obtained from 
cultures grown in the absence of RIPs. **p<0.01 (8 hours); ****p<0.0001 (16, 24, 48, 72, 96 
hours), Anova/ Bonferroni. 
3.2. Assessment of apoptosis 
3.2.1. Microscopic analysis with phase-contrast 
The presence of cellular morphological changes in NB100 cells treated for 24 and 48 
hours with ebulin l and nigrin b was examined by phase-contrast microscopy. After 24 
hours of treatment, NB100 cells showed a lower cell density compared to controls; cells 
also appeared with a certain cytoplasmic granulation attributable to the presence of 
vacuoles. After 48 hours of intoxication, apoptotic morphological changes, such as cell 
shrinkage, formation of membrane vesicles and cytoplasmic condensation, became 
clearly evident (figure 3.2). 
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Fig. 3.2. NB100 cells morphology by phase-contrast microscopy: untreated (a, d) and treated 
with ebulin l 10-7M (b, e) and nigrin b 10-7M (c, f) for 24 and 48 hours, respectively (400× 
magnification). 
3.2.2 Cytofluorimetric analysis  
Apoptosis was monitored by double staining with Annexin V/PI through flow 
cytofluorimetric analysis of NB100 cells. PI-positive cells are in the upper left quadrant, 
while cells in late apoptosis and early apoptosis are in the upper and lower right 
quadrants, respectively. After 24 hours of intoxication with RIPs, only about 2% of 
treated cells were in late stage apoptosis; this percentage increased over time to about 
13% at 48 hours for both RIPs (figure 3.3). The positivity to Annexin V/PI in flow 
cytofluorimetric analysis confirmed the induction of apoptosis after treatment of NB100 
cells with ebulin l and nigrin b. Despite the high RIP doses used, no necrosis was 
detectable. 
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Fig. 3.3. Evaluation of apoptosis/necrosis by Annexin V-EGFP/PI staining, followed by flow 
cytometry analysis. Representative plots of Annexin V (FITC channel)/PI (PE channel) staining 
of NB100 cells untreated or treated with ebulin l (10-7M) and nigrin b (10-7M).  
 
Comparison of cell viability results with those obtained with Annexin V/IP showed a 
strong discrepancy. In fact, the percentage of dead cells in the samples treated with the 
two RIPs resulted lower in vitality experiments, obtained by MTS reduction assay 
(about 40% and 80% at 24 and 48 hours, respectively), compared to the percentage of 
cells positive to Annexin V and/or to IP (about 3% and 15% at 24 and 48 hours, 
respectively). For this reason, cell viability was evaluated with alternative methods, 
such as the Trypan Blue vital exclusion test and the determination of cellular ATP in 
bioluminescence. Experiments were performed at 24 and 48 hours, expressing data as 
percentage of controls (as in MTS assay). The results obtained were compared with the 
values obtained with the MTS reduction assay. The graph showed that the viability of 
cells treated with ebulin l and nigrin b did not significantly vary when evaluated with 
the three methods (figure 3.4).  
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As the Trypan Blue test is the only method, among the three used, that allows to 
discriminate dead cells from viable cells, it was possible to express the data obtained 
with this method as percentage of dead cells with respect to the total cells, in order to 
compare them with those obtained with cytofluorimetric analysis. The percentages of 
dead cells obtained from the two methods resulted comparable (data not shown). 
Therefore, the discrepancy between viability data from Trypan Blue or cytofluorimetric 
analysis and those from MTS or ATP assay might be due to differences related to 
methodology dissimilarities of the assays. 
 
 
 
Fig. 3.4. Viability of NB100 cells (2×103 cells/well) treated with ebulin l (10-7M) and nigrin b 
(10-7M) after 24 and 48 hours. The viability assay based on MTS reduction (white columns) was 
compared with those based on the determination of the intracellular ATP (grey columns) and on 
Trypan Blue cell counting (black columns). The results are the means of three independent 
experiments, each performed in triplicate, and are presented as the percentage of control values 
obtained from cultures grown in the absence of RIPs. No significant differences were observed 
(confidence interval 95%, test Anova/Bonferroni). 
3.2.3 Caspase 3/7 activation 
In 2009 Bolognesi and co-workers described ricin and saporin capable to induce 
apoptotic caspase-dependent death at high concentrations in lymphoma cells (Polito et 
al., 2009a). To assess the involvement of caspase-dependent apoptosis, caspase 3/7 
activation was measured in NB100 cells exposed to 10-7M ebulin l and nigrin b in a time 
range from 4 to 72 hours. A strong time-dependent activation of caspase 3/7 was 
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observed, which became significantly higher than in control samples after 8 hours of 
treatment. The level of caspase activity grew exponentially over time, until reaching a 
plateau after 48 hours with 1352% and 922% activation values in cells treated with 
ebulin l and nigrin b, respectively, compared to untreated cells (figure 3.5). 
 
Fig. 3.5. Caspase 3/7 activation (columns) in NB100 cells (2×103 cells/well) treated with ebulin 
l (10-7M) and nigrin b (10-7M), compared with cell viability (♦). Caspase activity was expressed 
as the percentage of control values obtained from cultures grown in the absence of RIPs. The 
results are the means of three independent experiments, each performed in triplicate. 
****p<0.0001, Anova/ Bonferroni test. 
 
A comparison between non-toxic type 2 RIPs and stenodactylin, ricin and saporin, 
tested on the same cell line, revealed a strong activation of caspase 3/7 with all these 
RIPs; however, the extent of activation was lesser in cells treated with ebulin l and 
nigrin b in the first 24 hours of treatment. After 48 hours of treatment, both ebulin l and 
nigrin b induced a caspase activation comparable to those obtained after 24 hours with 
toxic RIPs at much lower concentrations (table 3.3). This demonstrates that the two 
RIPs from Sambucus are able to activate an apoptotic caspase-dependent mechanism of 
the same magnitude compared with other RIPs, but they need higher concentrations and 
longer times. 
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Table 3.3: Comparison of caspase 3/7 activation induced by the non-toxic type 2 RIPs ebulin l 
(10-7M) and nigrin b (10-7M), the toxic type 2 RIPs ricin (10-13M) and stenodactylin (10-14M) 
and the type 1 RIP saporin (10-11M), at 24 and 48 hours in NB100 cells. 
 
 
3.3 Evaluation of cytotoxicity by inhibitors of specific cell death 
pathways 
Further studies have been done in order to evaluate the involvement of the apoptotic 
process and/or alternative death processes induced by the two RIPs from Sambucus. For 
this purpose cytotoxicity experiments have been conducted in the presence of specific 
inhibitors of some cell death pathways such as the pan-caspasic inhibitor Z-VAD-fmk 
(Z-VAD) and the inhibitor of necroptosis, necrostatin-1. 
3.3.1. Caspase-dependent apoptosis inhibition by Z-VAD-fmk 
To deeper the role of caspase-dependent programmed cell death, the pan-caspase 
inhibitor Z-VAD was used to selectively inhibit the apoptotic pathway, as the inhibitor 
irreversibly binds to the catalytic site of caspase. NB100 cells were pretreated and 
maintained in Z-VAD (100 µM) and cell viability was determined with the MTS 
reduction assay in a time interval from 24 to 96 hours. After 24 hours, a slight but not 
significant improvement in the survival of cells pretreated with Z-VAD was observed, 
compared with cells treated with the RIPs alone. However, a significant protective 
effect of the pan-caspase inhibitor was more evident at longer times of treatment. In 
particular, after 48 hours the viability increased from 16% to 41% in cells treated with 
ebulin l and from 18% to 46% in cells treated with nigrin b. Cell protection decreased 
over time: at 72 hours the viability passed from 10% to 35% in cells treated with ebulin 
l and from 10% to 30% in cells treated with nigrin b, while at 96 hours viability resulted 
31% and 24% for ebulin l and nigrin b, respectively (figure 3.6a). 
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A comparison of the two non-toxic type 2 RIPs with stenodactylin showed that after 24 
hours of treatment with stenodactylin, the presence of the inhibitor gave a total 
protection to the cells, as the viability increases from 2% to 95%. This total protection 
of the cell population was not found with ebulin l and nigrin b, for which the protection 
was only partial and became significant only after 48 hours of treatment (figure 3.6b). 
 
 
 
Fig. 3.6. Viability of NB100 cells (2×103 cells/well) treated with (a) ebulin l (10-7M) and nigrin 
b (10-7M) and (b) stenodactylin (10-12M ), alone (♦) or in the presence of 100 µM Z-VAD (□). 
The pan-caspase inhibitor was added 3 hours before the RIP, and the viability was observed 
after the indicating times. Viability was evaluated using a colorimetric assay based on MTS 
reduction. The results are the means of at least three independent experiments, each performed 
in triplicate, and are presented as the percentage of control values obtained from cultures grown 
in the absence of RIPs. ****p<0.0001, Anova/ Bonferroni test. 
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The lack of a total protection by the pan-caspase inhibitor was not caused by its 
inactivation. Z-VAD was added every 24 hours, and as reported in figure 3.7, the 
effector caspase were effectively maintained at the basal level even at long times of 
treatment. 
 
Fig. 3.7. Effect of ebulin l (10-7M) and nigrin b (10-7M) on cell viability (■) and caspase 3/7 
activity (columns) in NB100 cells. Cells were pretreated for 3 hours with 100 µM Z-VAD. The 
viability of NB100 cells was evaluated at the indicate times with a colorimetric assay based on 
MTS reduction. Caspase 3/7 activity and the cell viability are expressed as the percentage of 
control values obtained from cultures grown in the absence of RIPs. The results are the means 
of three independent experiments, each performed in triplicate. 
 
An interesting aspect can be observed at long times of treatment, where the protection 
given by Z-VAD seems to reach a plateau (about 30% of vitality). This indicates that 
about 30% of cells does not die if simultaneously incubated with Z-VAD, suggesting 
that for these cells the activation of another way of cell death is not possible. This may 
depend on the cell cycle or on metabolic status of the cells, but more probably on the 
genetic pattern of tumor cells. Genetic alterations could be responsible for the 
acquirement of cell resistance to death or for a different RIP intracellular routing and 
compartmentalization, possibly allowing the toxin to reach only a single molecular 
target. 
The morphological analysis of NB100 cells treated with ebulin l and nigrin b in the 
presence of Z-VAD was assessed by phase-contrast microscopy at 24 and 48 hours. 
After 24 hours of treatment, no morphological differences were observed between cells 
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treated with ebulin l and nigrin b alone with respect to those pretreated with Z-VAD. 
However, after 48 hours, there was a greater viability of the cells treated with Z-VAD 
than those treated with the RIPs alone (figure 3.8). 
 
 
 
Fig. 3.8. NB100 cells morphology by phase-contrast microscopy: untreated and treated with 
ebulin l (10-7M) and with nigrin b (10-7M) alone or in the presence of 100 µM Z-VAD at 24h 
and 48h (400× magnification). The pan-caspase inhibitor was added 3 hours before the RIP, and 
the viability was observed after the indicating times. 
 
NB100 cells were subjected to Annexin V/PI double staining after treatment with ebulin 
l and nigrin b in the presence or absence of the inhibitor. At 24 hours, only a slight 
difference in the number of apoptotic cells among cells treated with the two RIPs alone 
(2.2% for ebulin l and 1.8% for nigrin b) and cells pretreated with Z-VAD (1.4% for 
ebulin l and 0.9% for nigrin b). On the contrary, at 48 hours the difference was more 
marked with a decrease in the number of cells in advanced apoptosis, passing from 
13.9% to 5.1% for ebulin l and from 12.7% to 4.9% for nigrin b (figure 3.9). 
These results demonstrated the prevalence of apoptosis at 48 hours of treatment and 
suggested that at 24 hours the apoptotic pathway has still a secondary role in the cell 
death pathway triggered by the two RIPs from Sambucus. This shows a different 
behavior with respect to toxic type 2 RIPs and supports the hypothesis that Sambucus 
toxins kill cells by activating more than one cell death pathway, which is especially 
prevalent at 24 hours. 
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Fig. 3.9. Evaluation of apoptosis by Annexin V/PI staining, followed by flow cytometry 
analysis. Representative plots of Annexin V (FITC channel)/PI (PE channel) staining of NB100 
cells cultured untreated or treated with ebulin l (10-7M) and nigrin b (10-7M) alone or in the 
presence of 100 µM Z-VAD at 24h and 48h. The pan-caspase inhibitor was added 3 hours 
before the RIP, and the viability was observed after the indicating times. 
 
3.3.2 Evaluation of the involvement of necroptosis  
Necroptosis is a programmed necrosis that occurs due to tumor necrosis factor receptor 
(TNF-R) activation. The involvement of necroptosis has been described in the literature 
for other RIPs such as abrin, a toxic type 2 RIP (Bora et al., 2010). In particular, 
pretreatment of NB100 cells with the necroptosis inhibitor necrostatin-1 prior to 
stenodactylin incubation, preserved approximately 70% of cells after 24 h (Polito et al., 
2016a). When the apoptotic cell death is inhibited by Z-VAD, cells can still die through 
necroptosis (Declercq et al., 2009). Therefore, to determine the role of other possible 
toxic mechanisms induced by ebulin l and nigrin b, a set of experiments were performed 
using the inhibitor of necroptosis necrostatin-1, at a dose previously tested in our 
laboratory with other RIPs and that was not toxic to the cells, but protected them from 
necroptosis. 
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Necroptosis depends on the serin-threonine kinase receptor-interacting proteins 1 
(R.I.P1) and 3 (R.I.P3). R.I.P1 is crucial in necroptosis and its activity is inhibited by 
necrostatin-1 (Christofferson and Yuan, 2010). NB100 cells were treated and 
maintained in 100 µM necrostatin-1 and the cell viability was determined by MTS 
reduction assay at different times (24, 48 and 72 hours of incubation with the two RIPs). 
A slight increase of cell viability was observed at all the examined times. However, 
these differences were not significant for both RIPs. (figure 3.10). 
 
 
Fig. 3.10. Viability of NB100 cells (2×103 cells/well) treated with ebulin l (10-7M) and nigrin b 
(10-7M) alone (black) or in the presence of 100 µM necrostatin-1 (green). The necroptosis 
inhibitor was added 3 hours before the RIP and the viability was observed after the indicating 
times using a colorimetric assay based on MTS reduction. The results are the means of at least 
three independent experiments, each performed in triplicate, and are presented as the percentage 
of control values obtained from cultures grown in the absence of RIPs. No significant 
differences were observed (confidence interval 95%, test Anova/Bonferroni). 
3.4 Cell cycle analysis 
In order to assess if the reduced viability in cells treated with ebulin l and nigrin b 
depended on a cytostatic effect of these toxins, cell cycle analysis was performed. This 
could explain the reduced capacity of NB100 to metabolize the MTS in the first 24 
hours. The distribution of NB100 cells was evaluated depending on the cell cycle phase 
through the flow cytometric analysis after staining with PI. Figure 3.11 showed a very 
similar pattern of cell cycle between the samples untreated and those treated with the 
two RIPs. Therefore, it can be exclude a cell cycle block in the residual percentage of 
cells treated with the two RIPs in the first 24 hours. 
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Fig. 3.11. Effect on NB100 cell cycle distribution. Flow cytometric cell cycle analysis was 
performed using PI for the DNA staining of NB100 cells following 24 hours of treatment with 
ebulin l  (10-7M) and nigrin b (10-7M). 
3.5 Assessment of autophagy 
In 2015 Shang and co-workers demonstrated that the accumulation in the lysosomes of 
some S. nigra proteins, including SNA-V (nigrin b), in Hela cells, caused saturation and 
subsequent activation of alternative degradation pathways, such as autophagy. 
Autophagy is a cellular degradation process that involves the lysosomal breakdown of 
cytoplasmic components. It is maintained at basal level in most cells and contributes to 
the routine turnover of cytoplasmic components. After stress or pathological stimuli, its 
activation increases. The microtubule-associated protein light chain 3 (LC3) is a marker 
of autophagy and it is a major constituent of autophagosome. During autophagy, LC3 is 
cleaved to generate the cytosolic form LC3I, which is subsequently conjugated to 
phosphatidyl ethanolamine to form LC3II, which is in turn recruited to autophagosomal 
membranes (Kabeya et al., 2000). Autophagosomes fuse with lysosomes to form 
autophagolysosomes and intra-autophagosomal components are degraded by lysosomal 
hydrolases. At the same time, LC3-II located in autophagolysosomal lumen is degraded 
(Tanida et al., 2008). 
Western blot analysis of extracts from NB100 cells treated with ebulin l and nigrin b 
(10-7M) revealed the presence of only one band corresponding to LC3I (16 kDa), thus 
denying a possible involvement of autophagy in the cell death mechanism induced by 
ebulin l and nigrin b at 24 hours of treatment (figure 3.12). In order to assess the 
specificity of the antibody used, the autophagic response to chloroquine was also 
analyzed. Chloroquine inhibits the fusion of the autophagosome with lysosome and, 
consequently, the lysosomal protein degradation, resulting in accumulation of LC3II 
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levels. Under chloroquine stress (100 µM), there was an increase of the LC3II (14 kDa) 
of the same intensity, both in untreated and ebulin l-treated NB100 cells. The result 
confirmed no involvement of autophagy in cell death pathways triggered by Sambucus 
toxins. 
 
 
 
Fig. 3.12. Expression of LC3 after 24 hours by western blot analysis of extracts from NB100 
cells treated with nigrin b (10-7M) and with ebulin l (10-7M) alone (-) or in the presence of 100 
µM chloroquine (+). The 16 kDa band corresponds to LC3I, while the 14 kDa band corresponds 
to LC3II. The same blot was hybridized with anti-β-actin as loading control.  
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CONCLUSION 
To resume, in the present study ebulin l and nigrin b completely abolish neuroblastoma 
cell viability; however, they need more time and higher concentration to fully carry out 
their cytotoxic effect (10-7M, 96h) compared with toxic type 2 RIPs.  
The obtained results indicate that ebulin l and nigrin b are able to induce caspase-
dependent apoptosis, as revealed by the strong time-dependent activation of caspase 3/7. 
The activation results of the same entity of other toxic type 2 RIPs, but at a RIP 
concentration much higher and at periods longer than 24 hours. Despite the activation of 
caspase is highly significant after 8 hours, the pan-caspase inhibitor Z-VAD gave no 
significant protection to NB100 cells at the first 24 hours. This suggests that at this time 
the apoptotic pathway has still a secondary role in the cell death pathways triggered by 
the two RIPs from Sambucus, showing a different behavior with the respect to the cell 
death mechanisms induced by toxic type 2 RIPs. Moreover, an interesting aspect was 
observed after long time of treatment with Sambucus RIPs. In fact, when cells are pre-
treated with Z-VAD, about 30% of cells seems to become resistant to death, suggesting 
that the involvement of another cell death pathway is not possible. It remains unclear if 
this depends on the cell cycle arrest, on metabolic status of the cells or more probably 
on the altered genetic pattern of the tumor cells. 
In conclusion, the mechanism of cell death induced by ebulin l and nigrin b is partly due 
to caspase-dependent apoptosis and it may assume the existence of a further cell death 
pathway that would be prevalent at the early 24 hours of intoxication and that is 
different from necrosis, necroptosis and autophagy, as demonstrated. Moreover, a block 
of cell cycle can be excluded. After 24 hours, the apoptotic pathway becomes the main 
route of cell death. Further studies are required to understand other cell death 
mechanisms probably involved in the cell death pathway triggered by ebulin l and 
nigrin b, in order to clarify what happens at the first 24 hours of intoxication. 
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4.1 Materials 
RIPs  
Stenodactylin was purified from the caudex of Adenia stenodactyla as described by 
Stirpe et al., 2007. Ricin was purified from the seeds of Ricinus communis as described 
by Nicolson et al., 1974. Ebulin l was purified from the leaves of Sambucus ebulus as 
described by Girbés et al., 1993b. Nigrin b was purified from the bark of Sambucus 
nigra as described by Girbés et al., 1993a. 
Plants 
Plants were purchased from Exotica Botanical Rarities, Erkelenz-Golkrath, Germany, 
while A. kirkii from Mbuyu–Sukkulenten, Bielefeld, Germany. If not immediately used 
on arrival, plants were kept in the greenhouse of the Botanical Garden of the University 
of Bologna.  
Safety precautions 
Because other previously investigated Adenia plants had shown the presence of high 
amounts of potent toxins, stringent safety measures are employed during handling of 
Adenia tissues. The plants were carefully handled; direct or indirect contacts with skin 
or eyes were avoided. The preparation of extracts were conducted in closed equipments 
under a ventilated fume hood to prevent inhaling toxic aerosols.  
Cell cultures 
Human neuroblastoma cells (NB100) and human uterine cervix carcinoma cells (HeLa) 
were maintained in RPMI 1640 medium (Sigma-Aldrich) containing 10% heat-
inactivated foetal bovin serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin and 100 
µg/ml streptomycin (Sigma-Aldrich). All cells were cultured at 37˚C in a humidified 
environment with 5% CO2 in a HeraCell Haereus incubator (Hanau, Germany) and 
routinely checked for the absence of mycoplasma infection. Trypan Blue and 
trypsin/EDTA were obtained from BioWhittaker (Vervies, Belgium). Cytotoxicity was 
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evaluated using L-[4,5-3H] leucine purchased by GE Healthcare (Buckingam shire, 
UK). Flasks and plates were from Falcon (Franklin Lakes, NJ, USA). 
Antibodies  
Rabbit sera against ricin, volkensin and type 1 RIPs were prepared as described by 
Strocchi (Strocchi et al., 1992). Rabbit sera against stenodactylin e lanceolin were 
prepared as described by Stirpe et al., 2007. The alkaline phosphatase-conjugated anti-
rabbit IgG used for ELISA was purchased from Sigma, whereas the phosphatase 
substrate (4-nitrophenyl phosphate disodium salt hexahydrate) was purchased from 
Merk (Darmstadt, Germany). Western blot was performed with rabbit antibody against 
LC3 purchased from Cell Signaling Technology, Inc. (Danvers, Massachusetts, USA), 
while mouse antibody against actin and the horseradish peroxadise-conjugated anti-
rabbit or anti-mouse IgG were purchased from Sigma Aldrich. Antibodies were diluted 
following manufacturer’s instructions.  
Kits 
Caspase activity was evaluated using the luminescent kit Caspase-Glo™3/7 Assay 
(Promega Corporation, Wisconsin, USA). Morphological membrane changes were 
detected using Annexin V-EGFP/PI detection kit (Biovision, Mt. View, CA). Viability 
was measured using the colorimetric CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay (Promega), which contains a novel tetrazolium compound [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
MTS] and an electron coupling reagent (1-methoxy phenazine methosulfate, PMS). The 
mitochondrial potential changes were detected using the Mitochondria Staining Kit 
(Sigma Aldrich). Total DNA was extracted through DNeasy Minikit (Qiagen), while 
total RNA was isolated using the RNeasy Minikit (Qiagen). The PCR product was 
purified using the NucleoSpin® Gel and PCR Clean-up kit, while the plasmids were 
purified using Nucleo Spin Plasmid kit both purchased from MACHEREY-NAGEL. 
TA Cloning® Kit Dual Promoter used for ligation, the pCR™II cloning vector and the 
chemically competent E. coli INVαF’ were purchased from Invitrogen (Life 
technology-Carlsbad-CA, USA). The reverse transcriptase MuLV, the dNTPs were 
obtained from GeneAmp RNA PCR kit (Applied Biosystem, Roche, New Jersey, USA).  
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Reagents 
The scintillation liquid was the Ready-Gel (Beckman Instrument, Fullerton, USA). The 
reagents and the molecular weight standard were purchased from GE Healthcare. DAPI-
Antifade was from Resnova SRL, Genzano di Roma, Italy. The pan-caspase inhibitor Z-
VAD-fmk (carbobenzoxy-valyl-alanyl-aspartyl-[Omethyl]fluoromethylketone), was 
supplied by Vinci-Biochem (Florence, Italy). The Immobilon Western detection 
Reagent and the nitrocellulose membrane were purchased from Millipore (Milford, MA, 
USA). The inhibitor of necroptosis, necrostatin-1, was obtained from Sigma-Aldrich. 
Yeast RNA was purchased from Roche Diagnostics S.L. (Barcelona, Spain). Single-
stranded salmon sperm DNA was purchased from Sigma-Aldrich. The reagents, the gels 
and the standards for electrophoresis were purchased from GE Healthcare, Milan, Italy. 
The water used was prepared with a Milli-Q apparatus (Millipore, Milford, MAUSA). 
Other reagents used were from Merck (Darmstadt, Germany), Carlo Erba (Milano, 
Italy) and Sigma. All reagents were of analytical grade, and when possible RNAse-free.  
Instruments 
Sepharose CL-6B (an agarose-based, bead-formed matrix, containing 6% agarose) and 
Sephacryl S-100 (cross-linked copolymer of allyl dextran and N,N’-methylene 
bisacrylamide) were from GE Healthcare (Buckinghamshire, UK). Protein 
concentration was determined by UVICON 860 Spectrophotometer (Kontron 
Instruments, Milano, Italy). The protein were separated on SDS-PAGE using the the 
PhastSystem (GE-Healthcare) and then blotting using the Mini Protean 3 Cell electro-
blotting apparatus (Bio-Rad). The DNA/RNA content was determined by Beckman DU 
640 Spectrophotometer. Cell incorporated radioactivity was measured by a β-counter 
(Beckman Coulter, Fullerton,CA, USA). Morphological cell analysis was carried out by 
a phase-contrast microscope with a digital camera from Nikon Eclipse TS100 (Chiyoda, 
Tokyo, Japan). Fluorescence microscopy was performed with a Nikon Eclipse E600 
fluorescence microscope (Nikon instruments, Calenzano, Firenze). The luminescence 
was read using the Fluoroskan Ascent FL (Labsystem, Finland). Absorbance at 492 nm 
was measured by a microtiter plate reader Multiskan EX, ThermoLabsystem, (Helsinki, 
Finland). Flow cytometry analysis was done using the FACSAria BD analyzer (Franklin 
Lakes, New Jersey, USA). PCR was conducted using the thermal cycler Gene Amp 
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PCR system 2400 (Perkin Elmer). DNA and RNA bands were analyzed by UV-
transilluminator (254-312 nm) including in the imaging instrument GelDoc (Biorad). 
DNA sequencing Softwares 
A search for sequence similarity was performed with BLAST program available on-line 
(http://www.ncv.nlm.nih.gov/BLAST). Sequence alignment was performed using 
ClustelW available tool, included in Mega 7 program with the default parameters 
manually modified aligning a number of amino acids characteristic of the sequences, 
such as those of the active site for the A-chains and the cysteines for the B-chains. The 
aligned sequences were graphically represented by sequence logos created with 
WebLogo 3 (Di Maro et al., 2014). Kirkiin 3D structure was predicted using the 
program I-TASSER, (http://zhanglab.ccmb.med.umich.edu/I-TASSER/), which used as 
comparative models the structures of abrin (1abr), viscumin (2rg9) and ricin (3px8) for 
kirkiin A-chain and the structures of cinnamomin (2vlc), ricin (2aai) and abrin (1abr) for 
kirkiin B-chain. The program Discovery Studio 3.5 suite (http://accelrys.com) was used 
for the graphical representation. Docking of the A-chain with adenine and 1α 
subdomain with lactose was predicted used COACH program included in I-TASSER; 
docking of 2γ subdomain was predicted used PATCHDOCK program 
(http://bioinfo3d.cs.tau.ac.il/PatchDock/). 
Statistical analysis 
Statistical analyses were conducted using the XLSTAT-Pro software, version 6.1.9 
(Addinsoft 2003). Results are given as means ± SD of three different experiments. Data 
were analyzed by Anova/Bonferroni test, followed by a comparison with Dunnett’s test. 
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4.2 Methods 
4.2.1 Adenia lectin purification 
Lectins from A. epigea, A. lindenii, A. monodelpha and A. kirkii caudices were purified 
as described in Pelosi et al., 2005. Samples of caudices (4–16 g each, approximately) 
were decorticated, minced with scissors and homogenized with an Ultra-Turrax with 5 
ml/g of phosphate-buffered saline (PBS, 0.14 M NaCl containing 5 mM sodium 
phosphate buffer, pH 7.4). After overnight stirring at 4°C, each extract was strained 
through cheesecloth and centrifuged at 18,000 × g for 30 minutes at 4°C. Crude extracts 
were adjusted to 100% saturation with solid (NH4)2SO4 and stored at 4°C until the 
following step. The (NH4)2SO4 precipitated material was collected by centrifugation, 
resuspended in PBS, dialysed against PBS and loaded into a Sepharose CL-6B column 
(14cm h × 1cm Ø). The column was previously treated with 0.2 M HCl for 150 min at 
50°C to cleave the polysaccharide chains in the matrix, thus exposing additional 
terminal galactosyl residues; then, the column was extensively washed and equilibrated 
with PBS. After loading the extract, the column was washed with PBS and the peak was 
eluted with 0.2 M galactose in PBS. The eluted protein was dialysed against PBS. 
Lectins were analyzed by 20% SDS-PAGE both under reducing and non-reducing 
conditions. 
4.2.2. Adenia kirkii lectin purification 
About 500g of A. kirkii caudex were decorticated and homogenized with an Ultra-
Turrax, as previously described for Adenia lectins (section 4.2.1). Since the material 
was very compact, 450 ml of PBS were added. After overnight stirring at 4°C, the 
extract was strained through cheesecloth and centrifuged at 18,000 × g at 4°C for 30 
min. The crude extract was further centrifuged to obtain a clear supernatant. The total 
recovered volume was 2790 ml, of which 2290 ml were adjusted to 100% saturation 
with solid (NH4)2SO4 and stored at 4°C, whereas the remaining 500 ml were loaded into 
a Sepharose CL-6B column (7cm h × 5cm Ø) pre-treated with 0.2 M HCl, as previously 
described. The peak was eluted with 0.2 M galactose. The 38 ml obtained from CL-6B 
were concentrated to 2 ml on YM10 membrane under nitrogen pressure, and loaded into 
a Sephacryl S-100 column (94 cm h × 1.5 cm Ø), in order to separate the lectins 
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according to the size. Representative fractions of the S-100 protein peaks were analyzed 
on a PhastGel Homogeneus 20 in a Phast System, following the supplier’s protocol. The 
protein fractions corresponding to the two purified lectins were collected and analyzed 
on a 8-25% PhastGel gradient, in order to obtain a greater resolution and to verify the 
purity of the bands. 
4.2.3. Chemico-physical characterization of lectins 
Lectins were analyzed by SDS-PAGE (see section 4.2.23). The isoelectric point was 
determined using a 20% polyacrylamide IEF gel 3-9 in a Phast System. The running and 
staining with Coomassie Brilliant Blue were performed following the supplier’s 
protocol. 
The determination of the protein content of crude extract and not retained material by 
Sepharose CL-6B was performed by spectrophotometric analysis at 230 nm, 260 nm 
and 320 nm, using the Kalb and Bernlohr method, which reduces the interference of the 
polyphenols present in the plant extract (Kalb and Bernlohr, 1977). The protein content 
of Sephacryl S-100 fractions was determined by spectrophotometric analysis at 280 nm. 
4.2.4. Haemagglutinating activity 
Haemagglutinating activity was determined in 96 wells microtiter plates. Each well 
contained 50 µl of a 2% suspension of human erythrocytes (group 0, Rh+) and 2-fold 
serial dilutions of the lectins, in a final volume of 100 µl. The plates were gently shaken 
and after about 1 hour at room temperature (25°C) the presence/absence of 
agglutination was visually examined.  
4.2.5 Enzyme-linked immunosorbent assay (ELISA) 
The cross-reactivity of kirkiin was performed by Enzym Linked Immunosorbent Assay 
(ELISA), using antibodies against several RIPs both type 1 and type 2. In 96-well 
microtiter plates 2 µg per well of kirkiin were added in 100 µl of 50 mM carbonate 
buffer pH 9.0 containing 15 mM sodium carbonate and 35 mM sodium bicarbonate. The 
plate was left overnight at 4°C so that the RIP could adhere to the well. After 5 washes 
with 200 ml PBS/Tween (137 mM NaCl, 1.5 mM KH2PO4, 8 mM Na2HPO4*12H2O, 
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0.05% (v/v) Tween 20), 200 µl of 0.5 mg/ml BSA (bovine serum albumin) were added, 
in order to saturate the charges of the well. After 1 hour of incubation at 37°C, 5 washes 
were performed with 200 µl of PBS/Tween and then reciprocal serum dilutions (from 
1:100 to 1:12800) were added (100 µl/well). The dilutions were prepared in 50 mM 
lactose, 50 mM mannose and 0,05% Tween 20. After 3 hours of incubation at 37°C and 
5 washes with 200 µl of PBS/Tween, 100 µl of anti-rabbit secondary antibody (1:7000) 
conjugated to alkaline phosphatase were added and incubated 1 hour at 37 °C. After 5 
washes with 200 µl PBS/Tween, 100 µl of 1 mg/ml enzyme substrate (4-nitrophenyl 
phosphate disodium) dissolved in buffer containing 1 M diethalonamine, 0.5 M MgCl2 
* 6H2O and 3 mM NaN3 were added. The absorption was measured at 405 nm with a 
Multiskan EX microtiter plate reader. 
4.2.6 rRNA glycosylase activity  
N-glycosylase activity of kirkiin was assessed by analysing the release of the diagnostic 
fragment upon treatment with acid aniline. Rabbit reticulocytes lysate (40 µl) and S-30 
lysate  from yeast (25 µl) were incubated with 3µg of RIP at 37°C for 1 hour. 2 µl of 0.5 
M EDTA pH 8 and 500 µl of 50 mM Tris-HCl (pH 7.8) and 0.5% SDS (p/v) were added 
and the samples were vigorously vortexed for 30 seconds to dissociate the ribosomal 
proteins. After a phenol extraction, in order to eliminate the proteins, the samples were 
centrifuged for 5 minutes at 10,000 x g and the aqueous phase was recovered. The RNA 
was precipitate at -80°C overnight by adding 0.1 volumes of 3 M sodium acetate pH 5.2 
and 3 volumes of absolute ethanol. RNA was centrifuged for 15 minutes at  10,000 x g 
at 4°C and the pellet was washed with 70% ethanol (v/v) and then centrifuged again. 
The pellet was dried at room temperature and then resuspended in 20µl of sterile H2O 
Mill Q. RNA was treated with 20 µl of 2 M aniline acetate pH 4.5 on ice for 10 minutes 
in the dark. After adding 200 µl of sterile water, RNA was extracted with ether saturated 
with water. The aqueous phase was precipitated at -80°C overnight by adding 0.1 
volumes of 3 M sodium acetate pH 5.2 and 3 volumes of absolute ethanol. RNA was 
centrifuged for 15 minutes at 10,000 x g at 4°C and the pellet was washed with 70% 
ethanol (v/v) and then centrifuged again. The pellet was resuspended in 20 µl of sterile 
water and the concentration was determined by spectrophotometer. The RNAs were 
subjected to electrophoresis on 5% (w/v) polyacrylamide-7 M urea gel at 15 mA for a 
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suitable time (from 1 hour 30 min to 1 hour 50min) in order to better differentiate the 
Endo's fragment, and stained with ethidium bromide. 
4.2.7 Polynucleotide:adenosine glycosylase (PNAG) activity assay 
PNAG activity on salmon sperm DNA  
PNAG activity was determined by measuring the amount of adenine release from 
salmon sperm DNA (ssDNA). The assay was performed by incubation of 10 µg of 
ssDNA with 3 µg of RIP in 300 µl of a reaction mixture containing 1 M KCl and 0.5 M 
sodium acetate (pH 4.5) at 30 °C for 1 hour. DNA was precipitate at -80°C overnight by 
adding 0.1 volumes of 3 M sodium acetate pH 5.2 and 3 volumes of absolute ethanol. 
DNA was centrifuged for 15 minutes at 10,000 x g at 4°C and the adenine released from 
RIP-treated DNA were determined in the obtained supernatants by spectrophotometer at 
260 nm.  
 
PNAG activity on tobacco mosaic virus (TMV) 
The breakage of the virus capsid was performed by vigorously vortexing 100 µl of 
TMV (20 mg/ml) in 500 µl of 50 mM Tris-HCl (pH 7.8) and 0.5% SDS. RNA samples 
were extracted by phenolization and centrifuged for 10 minutes at 10,000 x g at room 
temperature. The surnatant was precipitated overnight at -80°C by adding 0.1 volumes 
of 3 M sodium acetate pH 5.2 and 3 volumes of absolute ethanol. RNA was centrifuged 
for 15 minutes at 10,000 x g at 4°C and the pellet was washed with 70% ethanol (v/v) 
and then centrifuged again. The pellet was dried at room temperature and then 
resuspended in 20 µl of sterile water. Then, 15 µg of TMV RNA were incubated with 3 
µg of the RIP at 37°C for 1 hour in a final volume of 25 µl TE buffer (10 mM Tris-HCl 
and 1 mM EDTA) pH 7.2.  
RNA was treated with 25 µl of 2 M aniline acetate pH 4.5 on ice for 10 minutes in the 
dark and then extracted with ether saturated with water. The aqueous phase was 
precipitated at -80°C over night by adding 0.1 volumes of 3 M sodium acetate pH 5.2 
and 3 volumes of absolute ethanol. RNA was centrifuged for 15 minutes at 10,000 x g at 
4°C and the pellet was washed with 70% ethanol (v/v) and then centrifuged again. The 
pellet was resuspended in 15 µl of steril water and the concentration was determined by 
spectrophotometer. RNA samples were subjected to electrophoresis at 15 mA for 1 hour 
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15 minutes in 5% (w/v) polyacrylamide-7 M urea gel and stained with ethidium 
bromide. 
4.2.8 Endonuclease activity on supercoiled plasmid DNA 
For the detection of the endonuclease activity of the RIP on circular DNA, pCR 2.1 was 
used. This plasmid was obtained in laboratory by purification from E. coli INVαF´ 
bacterial cells (Invitrogen). 200 ng of the plasmid were incubated at 37°C for 1 hour 
with 3 µg of RIP in a final volume of 10 µl of 10 mM Tris-HCl (pH 7.8), 50 mM NaCl 
and 50 mM KCl in presence/absence of 5 mM MgCl2. The samples were analyzed on 
0.8% agarose gel electrophoresis.  
4.2.9 Synthesis of DNA 
The caudex of A.kirkii was disrupted using mortar and pestle and grinded to a fine 
powder under liquid nitrogen. Total DNA was extracted through DNeasy Minikit 
(Qiagen), according to the manufacturer’s instruction.  
4.2.10 Synthesis of cDNA via reverse transcription (RT) 
The caudex of A.kirkii was disrupted using mortar and pestle and grinded to a fine 
powder under liquid nitrogen. Total RNA was extracted through RNeasy Minikit 
(Qiagen), according to the manufacturer’s instruction. Poly(A)-rich RNA was reverse 
transcripted using the synthetic oligonucleotide J1 
(5'CGTCTAGAGTCGACTAGTGC(T)20 3'). Approximately 1 µg of total RNA and 
1µl of RNAse inhibitor were incubated in a thermal cycler first at 65°C for 5 minutes 
and then at 23°C for 20 minutes. It was later cooled on ice for 1 minute and 15 µl of 
reaction mixture were added containing: 1×PCR Buffer II, 5 mM of MgCl2, 1 mM of 
each dNTP, 10 µM of J1, and 4 U/µl of MuLV reverse transcriptase (Roche). The 
reaction mixture was incubated 20 minutes at 23°C, 20 minutes at 42°C, 5 minutes at 
99°C to inactivate the enzyme and finally 5 minutes at 5°C. 
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4.2.11 Selection of the oligonucleotides for PCR amplification 
Gene-specific primers for full-length of kirkiin were designed and synthesized on 
volkensin sequence (CAD61022) and N-terminal sequences available for other Adenia 
RIPs. The alignment of N-terminal amino acid sequences of the A-chains showed that 
lanceolin A1 shared 15/18 amino acids residues with modeccin and both had a Phe as 
N-terminal amino acid. Volkensin A-chain showed a homology of 15/21 amino acids 
with both stenodactylin and lanceolin A2, whereas stenodactylin A-chain shared 21/21 
amino acids with that of lanceolin A2. Even B-chain N-terminal identity was very high, 
with the exception of the first three amino acid residues, which are identical only in 
stenodactylin and volkensin (Asp-Pro-Val) (Stirpe et al., 2007) (figure 4.1). 
 
 
Fig. 4.1. Amino acid alignment of the N-terminal of lanceolin A1, lanceolin A2, stenodactylin, 
modeccin and volkensin A- and B-chains. The single letter code represents amino acids. 
Identical residues (*), conserved substitutions (:) and semiconserved (.) substitutions are 
reported. X, unassigned amino acid positions. Data from Stirpe et al., 2007 
 
 
Three couple of primers were used to detect the full-length amino acid sequence of 
kirkiin (A2 degenerated and B1R for A-chain and part of the B-chain; B1 and B5 
reverse for B-chain; A2 and B5 reverse for the complete sequence). Another primer was 
designed in proximity of the N-terminal end of A-chain (A1), but it did not produced 
amplification. Primers were synthesized by Integrated DNA Technologies (Belgium). 
The primer sequences are reported in table 4.1. 
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Table 4.1. Primers sequences. 
 
A1 5' GTTTTCCCCAAGGTCATHTTCGAC 
3' 
A2 5' GCCACGGTAGAGAGRTACACT 3' 
B1R 5' AAGTCGTCTCCCCGGAAGGGC 3' 
B1 5' TGCCCTTCCGGGGAGACGACT3' 
B5R 5' TAGGAACCATTGCTGGTTGGA3' 
4.2.12 Kirkiin gene amplification 
For kirkiin gene amplification 2 µl of the above-synthesize cDNA (diluted 1:10) or 40 
ng/µl of total DNA were used, and 16 µl of master mix and 0.5 µM of each primers 
were added. A typical reaction master mix included 1×PCR buffer/Mg2+, 0.25 mM 
dNTPs Mix, 0.5 U/µl Taq Polymerase (Biotools, Madrid, Spain). PCR amplification 
was carried out as  reported in table 4.2. 
 
Table 4.2. PCR condition. 
 
Step Temperature 
°C Time 
N°. of 
cycles 
Initial 
denaturation 94 3 min 1 
Denaturation 94 30 sec 
40 Annealing 55 40 sec 
Extension 72 1-2 
min 
Final extension 72 10 min 1 
Hold 15   
  
 
Differences in PCR amplification are in the annealing temperature, which is based on 
the fusion temperature of each primers and in the extension time at 72°C, which 
depends on the size of the fragment of interest.  
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About 5 µl of the amplified products from each tube along with 3 µl of loading dye were 
separated on 0.8% agarose gel using 1X TAE buffer. HindIII/EcoRI double digest was 
used as DNA molecular weight marker. 
4.2.13 cDNA and DNA cloning 
The PCR product was purified using the NucleoSpin® Gel and PCR Clean-up kit 
(MACHEREY-NAGEL), according to the manufacturer’s instruction.  
The purified PCR product was ligated into the pCR™II cloning vector (figure 4.2) using 
the TA Cloning® Kit Dual Promoter (Invitrogen). For ligation, optimal molar ratio is 
1:3 of vector:insert. The components of ligation mixture was mixed into a 0.5 ml 
microcentrifuge tube and incubated at 23°C for 2 hours in a thermal cycler. The vector 
contains genes for ampicillin resistance and the enzyme β-galactosidase (lacZ) that 
make it possible to select for transformed bacteria. The cloning site is in the lacZ gene. 
The ligation mixture was used to transform the Chemically Competent E. coli INVαF´ 
cells (Invitrogen). The cells were provided as frozen 50 µl aliquots from TA Cloning® 
kit and were thawed on ice. The ligation mixture (5 µl) was gently pipetted into the 
competent cells and gently mixed. The samples were incubated on ice for 30 minutes 
and then heat shocked for 30 seconds in 42°C water bath and then placed on ice for 2 
minutes. After the heat shock, 250 µl of SOC medium, provided from the kit, was added 
onto each sample. SOC medium was previously prewarmed at room temperature. The 
samples were incubated at 37°C horizontally shaking at 225 rpm for 1 hour. 50 and 100 
µl of each sample was spreaded onto a prewarmed LB/amp plate with 40 µl of XGal 
from the 20 mg/ml stock. After 15 minutes, the plates were inverted and incubated at 
37°C overnight.  
Cells transformed with vectors containing recombinant DNA produced white colonies; 
cells transformed with plasmids that not have DNA insert interrupting the LacZ gene 
(i.e. only the vector) grew into blue colonies. The white colonies (lacZ-negative 
transformants ) were screened by PCR, dipping the colony into a PCR tube with a 
yellow tip and then streaking it onto a fresh agar plate using a numbered template. PCR 
was performed by using the appropriate couple of primers (M13 and M13R universal 
primers). The PCR mix included: 1×PCR Buffer, 0.25 mM dNTPs, 1 µM of each 
primers, 5 U/µl Taq Polymerase (Biotools). PCR amplification was performed with the 
PCR conditions reported in table 4.2. The hybridization temperature was 60°C for 30 
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seconds and the extension time at 72°C was 1 minute 30 seconds for A- and B-chains 
and 2 minutes 30 seconds for the entire sequence amplifications. 
 
 
 
Fig. 4.2. Map of the linearized vector pCR®II. Image from TA Cloning® Kit manual 
(Invitrogen). 
4.2.14 Purification of the plasmids 
The positive white colonies (LacZ-negative) were transferred from the agar plates to a 
Falcon tube each, containing 10 ml LB-medium with 100 µg/ml ampicillin, and 
incubated overnight at 37°C at 225 rpm. The cells were collected by centrifugation 
(2800 rpm for 10 minutes) and the plasmids were then purified using Nucleo Spin 
Plasmid kit (MACHEREY-NAGEL), according to the manufacturer’s instruction. The 
DNA content was determined by measuring the absorbance at 260 nm. The plasmid 
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quality and the presence of sequence fragment were checked by running the samples on 
a 0.8% agarose gel analysis by digestion with EcoRI enzyme. 
4.2.15 DNA sequence 
The purified plasmids were sequenced by CENIT Support system of Villamayor 
(Salamanca, Spain). The samples were prepared according to the manufacturer’s 
recommendations. 
4.2.16 Protein synthesis inhibition assay 
Cell-free system 
Cell-free protein synthesis for Adenia lectins was determined in vitro using a rabbit 
reticulocyte lysate system. 25 µl of rabbit reticulocyte lysate (prepared as described by 
Allen e Schweet, 1962) and 12.5 µl of a reaction mixture composed of 10 mM TrisHCl 
pH 7.4, 100 mM ammonium acetate, 2 mM Mg-acetate, 1 mM ATP, 0.2 mM GTP, 15 
mM creatine phosphate, 12 µU creatine kinase, 0.05 mM amino acids (without leucine), 
0.75 µCi L-[3H]leucine were added to appropriate dilutions of the lectins. The reaction 
tubes were incubated at 28°C under stirring for 7 minutes and blocked with 1 ml 0.1M 
KOH. After adding 25 µl of hydrogen peroxide to the tubes, 1 ml of 20% trichloroacetic 
acid (TCA) was added when the liquid was decolorized, in order to precipitate the 
proteins. The protein precipitate was collected on Whatman filters GF/C in suitable 
ampoules with 5% TCA. Then, 5 ml of Ready-Gel scintillation fluid (Beckman) 
containing 0.7% of acetic acid were added to the vials to break down any 
chemiluminescence. The radioactivity of L-[3H]leucine incorporated into new 
synthesized proteins was measured by β-counter. The same experiment was carried out 
under reducing conditions, with the addition of 1% 2-mercaptoethanol for 30 minutes at 
37°C. The experiments were conducted in duplicate and the inhibitory effect of proteins 
were represented as IC50 value, which is defined as the amount of inhibitory protein that 
gives 50% of protein synthesis inhibition, calculated by linear regression. 
 
 
 
  Chapter 4. Materials and methods 
   121 
Cell lines  
NB100 and HeLa cells (1×104 cells in 500 µl/well of complete medium RPMI) were 
seeded in 24-well plates. After 24 hours of incubation, the medium was removed and 
300 µl of kirkiin were added to the appropriate dilutions (from 10-15M to 10-11M), while 
the control samples were incubated only with the complete medium. After 72 hours of 
incubation with the RIP, the medium was removed and substituted with RPMI without 
leucine and containing 0.125 µCi/well of [3H]leucine. After 6 hours of incubation at 
37°C, 1 ml of 20% TCA per well was added. The plate was left for 30 minutes at 4°C to 
precipitate the proteins and subsequently, 3 washes with 5% TCA were performed. The 
cells were detached with 200 µl KOH 1 M for 10 minutes at 37°C. After a further wash 
with 0.1 M KOH, the content of each well was transferred in suitable vials and 5 ml of 
scintillation fluid were then added to each. The radioactivity of the [3H]leucine 
incorporated into the new synthesized proteins was determined by β-counter. The 
experiments were conducted in duplicate and IC50 values were calculated by linear 
regression. 
4.2.17 Cell viability assay 
Cell viability by MTS assay  
Cell viability was evaluated with the colorimetric assay CellTiter 96® Aqueous One 
Solution Cell Proliferation. The kit is a colorimetric assay which allows to measure the 
number of metabolically active cells, thus still viable. The MTS tetrazolium compound 
presents a yellow color and it is bioreduced by cells into a red colored formazan 
product, soluble in RPMI medium. The enzyme responsible for the reaction is a 
mitochondrial dehydrogenase that is present only in metabolically active cells. The 
compound conversion is presumably accomplished by NADPH or NADH produced by 
the enzyme. The quantity of formazan product is measured by measuring the 
absorbance at 490 nm and it is proportional to the number of viable cells.  
NB100 and HeLa cells (2×103 cells in 100 µl/well of complete medium RPMI) were 
seeded in 96-well microtiter plates. After 24 hours, cells were incubated with scalar 
dilutions of kirkiin (from 10-15M to 10-11M) and left for 72 hours. In addition, time-
course experiments were conducted on cells exposed to kirkiin (10-11M), ebulin l (10-
7M) and nigrin b (10-7M) in a range between 4 and 96 hours. After the indicated times, 
the medium was removed and CellTiter 96 Aqueous One Solution Reagent diluted 1: 6 
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was added in a final volume of 120 µl/well. After 1 hour of incubation at 37°C, the 
absorbance at 492 nm was measured. The results are the means of at least three 
experiments performed in triplicate. 
 
Cell viability by ATP assay 
This assay is based on the measurement of intracellular ATP produced by viable cells. 
The kit used is the CellTiter-Glo™ Luminescent Cell Viability Assay (Promega). It is 
based on the luciferin/luciferase reaction that generates the luminescent compound 
oxyluciferin in the presence of ATP. The luminescent signal is stable and linear (from 0 
to 50000 living cells) and directly proportional to the amount of ATP produced.  
NB100 cells (2x103cells in 100 µl/well of complete RPMI) were seeded in 96-well 
microtiter plates. After 24 hours, cells were incubated with ebulin l (10-7M) and nigrin b 
(10-7M). After the indicated times, the medium was removed and 100 µl of CellTiter-
Glo™ diluted 1:2 in complete RPMI were added. Plates were shaken at 420 rpm and 
incubated for 20 minutes in the dark at room temperature. The luminescence was 
measured by Fluoroskan Ascent FL (integration time 10 sec). 
 
Cell viability by trypan blue exclusion test 
Trypan Blue is a vital dye used to selectively stain viable cells. It is a negatively 
charged chromophore which is not able to cross the membrane of intact cells, but in 
dead cells it can easily penetrate, making them distinguishable from living cells with a 
rapid analysis with a simple microscopic observation. For the counting of the cells the 
Neubauer chamber was used and a solution containing 30 µl of 0.1% trypan blue, 65 µl 
RPMI and 5 µl cell suspension was prepared. 
 
Viability in the presence of cell-death inhibitors 
RIP toxicity was evaluated in association with the pan-caspase inhibitor Z-VAD-fmk 
(100 µM) and the necroptosis inhibitor necrostatin-1 (100 µM). The reagents were 
added to the culture 3 hours before RIP treatment and every 24 hours after RIP 
treatment.  
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4.2.18 Cell and nuclear morphology 
NB100 cells (2×103 cells in 100 µl/well of complete RPMI) were seeded in 24-well 
plates and after 24 hours, cells were incubated with kirkiin (10-11M), ebulin l (10-7M) 
and nigrin b (10-7M) in a range between 16, 24 and 48 hours at 37°C. Morphological 
analysis was assessed by phase contrast microscopy.  
For nuclear analysis, NB100 cells (2×104 in 500 µl/well of complete RPMI) were 
seeded directly on a coverslip in 24-well plates 48 hours prior the experiment. After 
treatment with kirkiin (10-11M) for 24 and 48 hours, cells were washed with PBS and 
fixed with methanol/acetic acid 1:3 for 20 minutes. After washing with PBS, the cells 
were incubated with 7 µl DAPI/antifade (4´,6-diamidino-2-phenylindole) and visualized 
under Nikon Eclipse E600W fluorescence microscope. 
4.2.19 Analysis of the mitochondrial membrane electrical potential gradient 
The mitochondrial membrane potential (∆ѱm) was measured using the cationic, 
lipophilic dye JC-1 (5,5',6,6'-tetrachloro-1,1´,3,3´-tetraethylbenzimidazolocarbocyanine 
iodide) contained in Mitochondria Staining Kit (Sigma). JC-1 selectively enters the 
mitochondria and reversibly change color from green to red as the membrane potential 
increases. In healthy cells with high ∆ψm, JC-1 forms J-aggregates yielding red 
fluorescence. In apoptotic or unhealthy cells the mitochondrial membrane potential 
dissipates and JC-1 remains in the monomeric form with green fluorescence. 
Cells (2×104 in 500 µl/well of complete RPMI) were seeded directly on a coverslip in 
24-well plates 48 hours prior the experiments. After treatment with kirkiin (10-11M) for 
24 and 48 hours cells were stained with 500 µl of JC-1 dye (1:100 in RPMI) and 
incubated at room temperature for 10 minutes in the dark. The cells were then washed 
three times with staining buffer purchased from the kit. The coverslips were inverted on 
glass slide and the cells were observed under Nikon Eclipse E600W fluorescence 
microscope. 
4.2.20 Assessment of apoptosis  
Apoptotic cell death was examined by flow cytometry using Annexin V-EGFP/PI 
detection kit and by luminometer measuring of caspase activation. Apoptosis inhibitor 
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Z-VAD was added 3 hours before treatment with the RIP. 
 
Quantification by flow cytometry 
Apoptotic cell death was examined by flow cytometry using Annexin V-EGFP/PI 
detection kit. Annexin V is a molecule able to bind to phosphatidylserine residues which 
are exposed on the cell membrane with the activation of apoptosis, while propidium 
iodide (PI) is a fluorescent DNA-intercalating molecule. 
NB100 cells (2×106/3 ml RPMI complete) were seeded in 25cm2 flasks and then treated 
with kirkiin (10-11M), ebulin l (10-7M) and nigrin b (10-7M). After the indicated times, 
the cells were centrifuged at 400 x g for 5 minutes, washed 2 times with cold PBS, 
centrifuged again and then resuspended in 294 µl binding buffer supplied with the kit. 
Annexin V-EGFP (3 µl) and propidium iodide (3 µl) were added and the tubes were 
incubated for 10 minutes in the dark at room temperature. The cells were analyzed by 
flow cytometry FACSAria (BD) using the FACSDiva software. 
 
Caspase 3/7 activation  
Caspase 3/7 activation was assessed by the luminescent assay Caspase-GloTM. The kit 
provides a luminogenic caspase substrate, which contains the tetrapeptide sequence 
specific for caspase 3/7 (DEVD). The caspase cleavages its substrate generating a 
luminescent signal, produced by luciferase. Luminescence is proportional to the amount 
of caspase activity present. 
NB100 cells (2×103 in 100 µl/well of complete RPMI) were seeded 96-well microtiter 
plates and after 24 hours, cells were incubated with kirkiin (10-11M), ebulin l (10-7M) 
and nigrin b (10-7M). After the indicated times, the medium was removed and 50 µl of 
Caspase-GloTM3/7 diluted 1:2 in complete RPMI were added. Plates were shaken at 
420 rpm and incubated for 20 minutes in the dark at room temperature. 
The luminescence was measured by Fluoroskan Ascent FL (integration time 10 
seconds) and the values were normalized for the viability. 
4.2.21 Cell cycle analysis by flow cytometry with PI 
The distribution of cell population in the different phases of the cell cycle was examined 
by flow cytometric analysis after staining with PI.  
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NB100 cells (2×105 in 3 ml of RPMI complete) were seeded in 25cm2 flasks and then 
treated with ebulin l (10-7M) and nigrin b (10-7M). After 24 hours of treatment, the cells 
were centrifuged at 400xg for 5 minutes, washed 2 times with cold PBS, centrifuged 
again and fixed by adding 70% cold ethanol drop by drop, vortexing the samples. The 
samples were then stained with a solution containing 5 µg/ml PI, 0.1% Triton and 50 
µg/ml RNAsi. The solution was boiled for 5 minutes to obtain a DNAse free solution. 
The cells were analyzed by flow cytometry FACSAria (BD) using the FACSDiva 
software. The intensity of the fluorescent is proportional to the amount of DNA within 
the cells: cells in G2 and M phases have a double DNA amount compared to cells in G1 
phase, while cells in S phase have an intermediate amount of DNA, as they are in the 
replication process.  
4.2.22 Assessment of autophagy 
Cells (1×106/20 ml RPMI complete) were seeded in 75 cm2 flasks and after 24 hours, 
were treated with ebulin l (10-7M) and nigrin b (10-7M). At 24 hours of treatment, cells 
were centrifugated at 500 × g for 5 minutes at room temperature. Cell pellets were lysed 
by adding 100 µl of Cell Lytic-M (Sigma-Aldrich) supplemented with protease inhibitor 
cocktail (1:100), phosphatase inhibitor cocktail 1 (1:100) and sodium-orthovanadate 
(1:500). After 45 minutes on ice, vortexing every 5 minutes, the samples were 
centrifugated at 12,000 × g for 25 minutes at 4°C in order to remove the insoluble 
material. Protein supernatant (cell lysate) was collected and stored at -20°C. Protein 
content was quantified by spectrophotometer by Bradford assay. The protein (50 
µg/lane) were separated by 10% SDS-PAGE and blotted for 45 minutes at 100V to 
nitrocellulose membrane (Millipore). Non-specific antibody binding sites were blocked 
by incubation with blocking buffer, containing TBS/Tween (TRIS buffered saline, 0.1% 
Tween 20) and 5% milk powder for 1 hour at room temperature. After 3 washes with 
TBS/Tween, membranes was incubated overnight at 4°C with the primary antibodies 
anti-LC3 (1:500), direct against LC3I (16 kDa) and LC3II (14 kDa), and monoclonal 
anti-β-actin (1:6000), which detects β-actin (42 kDa) used as protein loading control. 
All antibodies were diluted in TBS/Tween with 5% bovine serum albumin. After 3 
washes with TBS/Tween, membranes were incubated for 1 hour at room temperature 
with horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibody 
(Sigma) (diluted 1:6000 for LC3 and 1:13000 for β-actin) in blocking buffer. After 
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further 3 washes, proteins were detected by incubating the membrane with Immobilon 
Western detection Reagent (Millipore), according to manufacturer’s protocol and the 
image was taken on Kodak® BioMax light Film.  
4.2.23 SDS- PAGE  
Proteins were incubated in sample buffer (40 mM Tris/HCl pH 6.8, 2% SDS, 0.005% 
bromophenol blue) containing 0.5% (v/v) 2-mercaptoethanol (reducing conditions), or 1 
mg/ml iodoacetamide (non-reducing conditions) for 20 minutes at 37°C. The gel was 
stained with 0.1% (w/v) Coomassie Brilliant Blue G250 in 50% methanol and 10% 
acetic acid, following the protocol recommended by the manufacturer (GE Healthcare). 
4.2.24 RNA electrophoresis on 5% polyacrylamide-7M urea gel 
Ribosomal RNA was analyzed using 5% (w/v) polyacrylamide in denaturating 
conditions with 7 M urea. RNA samples were incubated in loading buffer containing 
150 mg/ml sucrose, 7 M urea, 0.4 µg/ml bromophenol blue and 1XTBE buffer (45 mM 
Tris, 45 mM boric acid, 1 mM EDTA pH 8). After boiling the samples for 30 seconds, 
the run was performed at 15 mA for 1h 15 min/1h 50 min, approximately, using TBE 
buffer. The gel was stained with 10 µl ethidium bromide (20 mg/ml) in 10 ml TBE 
buffer for 20-30 minutes and RNA bands were analyzed by UV-transilluminator (254-
312 nm) including in the imaging instrument GelDoc (Biorad). 
4.2.25 DNA electrophoresis on agarose gel 
DNA was analyzed using 0.8% agarose gel in TAE (0.04 M Tris, 0.04 M acetate, 1 mM 
EDTA, pH 8.0) buffer. The samples were incubated in loading buffer (containing 45% 
glycerol (v/v), 10% of 10XTAE and 0.025% bromophenol blue). The run was 
performed at 90 V for 50 minutes, approximately, using TAE buffer. The gel was 
stained with a fluorescent solution, containing 10 µl GelRed (10000X) in 100 ml TAE 
buffer for 20-30 minutes. DNA bands were analyzed by UV-transilluminator (254-312 
nm) including in the imaging instrument GelDoc (Biorad). 
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